"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","35/130","72/2914",5.43940650600569e-30,3.57369007444574e-27,2.14140845604856e-27,"EGFR/FGFR1/FGFR3/FGFR4/MET/PDGFRA/PDGFRB/AREG/ERBB2/PIK3CA/EREG/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/ESR1/FGF7/FGF8/FGF9/FYN/PDGFA/PDGFB/SRC/LCK/TGFA/PIK3R1/RAC1",35
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","38/130","97/2914",2.97938392572679e-28,9.78727619601249e-26,5.86468204327273e-26,"EGFR/FGFR1/FGFR3/FGFR4/MET/PDGFRA/PDGFRB/AREG/ERBB2/PIK3CA/GSK3A/GSK3B/MDM2/EREG/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/ESR1/FGF7/FGF8/FGF9/FYN/PDGFA/PDGFB/SRC/LCK/TGFA/PIK3R1/RAC1",38
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","64/130","347/2914",2.8402782179312e-27,6.22020929726934e-25,3.72724229300446e-25,"CDK5/EGFR/FGFR1/FGFR3/FGFR4/FLT4/MAPK14/MET/PDGFRA/PDGFRB/RPS6KA3/STAT1/STAT3/AREG/CBL/CTNNB1/ERBB2/PIK3CA/PRKCD/MAP2K1/EREG/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/ESR1/FGF7/FGF8/FGF9/FLT3LG/IGF2/NGF/BDNF/NTF3/NTF4/FYN/NTRK2/PTK2/PDGFA/PDGFB/SRC/PDGFC/PDGFD/PGF/LCK/LYN/MAPK3/TGFA/CDC42/PIK3R1/PRKCA/RAC1/VEGFA/VEGFB/VEGFC/VEGFD",64
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","36/130","92/2914",1.06403497915223e-26,1.74767745325754e-24,1.04723442684983e-24,"EGFR/FGFR1/FGFR3/FGFR4/MET/PDGFRA/PDGFRB/AREG/ERBB2/PIK3CA/EREG/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/ESR1/FGF7/FGF8/FGF9/FYN/PDGFA/PDGFB/SRC/LCK/MAPK3/TGFA/PIK3R1/RAC1",36
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","36/130","99/2914",2.27391809930363e-25,2.98792838248497e-23,1.7904113034517e-23,"EGFR/FGFR1/FGFR3/FGFR4/MET/PDGFRA/PDGFRB/AREG/ERBB2/PIK3CA/EREG/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/ESR1/FGF7/FGF8/FGF9/FYN/PDGFA/PDGFB/SRC/LCK/MAPK3/TGFA/PIK3R1/RAC1",36
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","54/130","268/2914",2.41416132643393e-24,2.64350665244516e-22,1.58402865980051e-22,"CREBBP/EGFR/FGFR1/FGFR3/FGFR4/MET/PDGFRA/PDGFRB/STAT1/STAT3/AREG/CBL/CTNNB1/ERBB2/PIK3CA/AXIN1/EP300/FBXW7/GSK3A/GSK3B/MAP2K1/MDM2/EREG/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/ESR1/FGF7/FGF8/FGF9/FYN/PDGFA/PDGFB/SRC/LCK/MAPK3/NOTCH1/TGFA/PIK3R1/RAC1/SMAD2/SMAD3/SMAD4/TGFBR1/TCF7L2",54
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","41/130","172/2914",5.80230319058948e-21,5.44587599459612e-19,3.26325021545934e-19,"EGFR/FGFR1/FGFR3/FGFR4/MET/PDGFRA/PDGFRB/AREG/ERBB2/PIK3CA/GSK3A/GSK3B/MDM2/TP53/EREG/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/ESR1/FGF7/FGF8/FGF9/FYN/PDGFA/PDGFB/SRC/LCK/MAPK3/TGFA/PIK3R1/RAC1/JUN",41
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","43/130","201/2914",4.81200500708948e-20,3.95185911207223e-18,2.36801299033087e-18,"EGFR/FGFR1/FGFR3/FGFR4/MET/PDGFRA/PDGFRB/AREG/ERBB2/PIK3CA/PRKCD/GSK3A/GSK3B/MDM2/TP53/EREG/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/ESR1/FGF7/FGF8/FGF9/FYN/PDGFA/PDGFB/SRC/LCK/MAPK3/TGFA/PIK3R1/PRKCA/RAC1/JUN",43
"R-HSA-5654695","R-HSA-5654695","PI-3K cascade:FGFR2","17/130","23/2914",3.10725289101098e-19,2.04676541642008e-17,1.22645240045039e-17,"PIK3CA/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/PIK3R1",17
"R-HSA-2033519","R-HSA-2033519","Activated point mutants of FGFR2","15/130","17/2914",3.11532026852371e-19,2.04676541642008e-17,1.22645240045039e-17,"FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9",15
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","22/130","45/2914",5.68192166417748e-19,3.39365684851328e-17,2.03352985875826e-17,"FGFR1/FGFR3/FGFR4/STAT1/STAT3/PIK3CA/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/PIK3R1",22
"R-HSA-190241","R-HSA-190241","FGFR2 ligand binding and activation","15/130","18/2914",1.79965382015557e-18,9.09517353724776e-17,5.44996379545087e-17,"FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9",15
"R-HSA-5654221","R-HSA-5654221","Phospholipase C-mediated cascade; FGFR2","15/130","18/2914",1.79965382015557e-18,9.09517353724776e-17,5.44996379545087e-17,"FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9",15
"R-HSA-109704","R-HSA-109704","PI3K Cascade","21/130","42/2914",2.11030712693292e-18,9.9033698742495e-17,5.9342471088189e-17,"FGFR1/FGFR3/FGFR4/PIK3CA/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/FLT3LG/PIK3R1",21
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","41/130","202/2914",3.69441820378727e-18,1.61815517325883e-16,9.69622742608028e-17,"ANGPT1/EGFR/FGFR1/FGFR3/FGFR4/MET/PDGFRA/PDGFRB/RET/TEK/AREG/CDK1/ERBB2/MAP2K1/EREG/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/FLT3LG/FYN/PTK2/PDGFA/PDGFB/SRC/MAPK3/TGFA/CDC42/RAC1/JUN",41
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","23/130","55/2914",6.97553708738354e-18,2.86432991650687e-16,1.71634925702727e-16,"FGFR1/FGFR3/FGFR4/CBL/PIK3CA/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/SRC/MAPK3/PIK3R1",23
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","22/130","50/2914",1.02001053387894e-17,3.94204071034389e-16,2.36212965740385e-16,"FGFR1/FGFR3/FGFR4/PIK3CA/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/FLT3LG/IGF2/PIK3R1",22
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","38/130","177/2914",1.14407048366434e-17,4.17585726537482e-16,2.50223602859919e-16,"ANGPT1/EGFR/FGFR1/FGFR3/FGFR4/MET/PDGFRA/PDGFRB/RET/TEK/AREG/CDK1/ERBB2/MAP2K1/EREG/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/FLT3LG/FYN/PTK2/PDGFA/PDGFB/SRC/MAPK3/TGFA",38
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","39/130","188/2914",1.37239215998416e-17,4.74558762689261e-16,2.84362696860985e-16,"ANGPT1/EGFR/FGFR1/FGFR3/FGFR4/MET/PDGFRA/PDGFRB/RET/TEK/AREG/ERBB2/PIK3CA/MAP2K1/EREG/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/FLT3LG/FYN/PTK2/PDGFA/PDGFB/SRC/MAPK3/TGFA/PIK3R1",39
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","22/130","51/2914",1.72927066690164e-17,5.41014680073512e-16,3.24184074897851e-16,"FGFR1/FGFR3/FGFR4/PIK3CA/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/FLT3LG/IGF2/PIK3R1",22
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","22/130","51/2914",1.72927066690164e-17,5.41014680073512e-16,3.24184074897851e-16,"FGFR1/FGFR3/FGFR4/PIK3CA/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/FLT3LG/IGF2/PIK3R1",22
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","21/130","46/2914",2.34931512824179e-17,7.01590926934026e-16,4.20403759790636e-16,"FGFR1/FGFR3/FGFR4/PIK3CA/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/FLT3LG/PIK3R1",21
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","37/130","171/2914",2.59938144304221e-17,7.42518960034232e-16,4.44928448374273e-16,"ANGPT1/EGFR/FGFR1/FGFR3/FGFR4/MET/PDGFRA/PDGFRB/RET/TEK/AREG/ERBB2/MAP2K1/EREG/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/FLT3LG/FYN/PTK2/PDGFA/PDGFB/SRC/MAPK3/TGFA",37
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","22/130","52/2914",2.88952907871152e-17,7.59368241885387e-16,4.55024789658151e-16,"FGFR1/FGFR3/FGFR4/PIK3CA/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/FLT3LG/MAPK3/PIK3R1",22
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","22/130","52/2914",2.88952907871152e-17,7.59368241885387e-16,4.55024789658151e-16,"FGFR1/FGFR3/FGFR4/PIK3CA/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/FLT3LG/MAPK3/PIK3R1",22
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","18/130","32/2914",4.20157278313326e-17,1.06170512250713e-15,6.36189563114105e-16,"CBL/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/SRC/MAPK3",18
"R-HSA-5654689","R-HSA-5654689","PI-3K cascade:FGFR1","15/130","21/2914",1.06806702869705e-16,2.59896310316283e-15,1.55733749993255e-15,"FGFR1/PIK3CA/FGF1/FGF10/FGF17/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF8/FGF9/PIK3R1",15
"R-HSA-190242","R-HSA-190242","FGFR1 ligand binding and activation","13/130","15/2914",1.49011809079632e-16,3.49645566304708e-15,2.09512844345046e-15,"FGFR1/FGF1/FGF10/FGF17/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF8/FGF9",13
"R-HSA-5654696","R-HSA-5654696","Downstream signaling of activated FGFR2","17/130","30/2914",2.83316174404825e-16,6.41857677875759e-15,3.84610704999653e-15,"PIK3CA/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/PIK3R1",17
"R-HSA-1839126","R-HSA-1839126","FGFR2 mutant receptor activation","15/130","22/2914",3.23181699559381e-16,7.07767922035043e-15,4.24105107491959e-15,"FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9",15
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","19/130","41/2914",6.27858954311092e-16,1.33065591284641e-14,7.9734889274142e-15,"FGFR1/CBL/PIK3CA/FGF1/FGF10/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF8/FGF9/SRC/MAPK3/PIK3R1",19
"R-HSA-5654219","R-HSA-5654219","Phospholipase C-mediated cascade: FGFR1","13/130","16/2914",7.64959719484003e-16,1.57055792406559e-14,9.41101760154661e-15,"FGFR1/FGF1/FGF10/FGF17/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF8/FGF9",13
"R-HSA-5654699","R-HSA-5654699","SHC-mediated cascade:FGFR2","15/130","23/2914",8.94551601347028e-16,1.75209412879191e-14,1.04988096478118e-14,"FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9",15
"R-HSA-1643685","R-HSA-1643685","Disease","57/130","443/2914",9.06715378674657e-16,1.75209412879191e-14,1.04988096478118e-14,"CDK5/CREBBP/EGFR/FGFR1/FGFR3/FGFR4/MET/PDGFRA/PDGFRB/STAT1/STAT3/AREG/CBL/CTNNB1/ERBB2/PIK3CA/AXIN1/EP300/FBXW7/GSK3A/GSK3B/MAP2K1/MDM2/EREG/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/ESR1/FGF7/FGF8/FGF9/FYN/PDGFA/PDGFB/SRC/LCK/MAPK3/NOTCH1/TGFA/PIK3R1/RAC1/SMAD2/SMAD3/SMAD4/TGFBR1/NFKB1/TCF7L2/JUN",57
"R-HSA-5655253","R-HSA-5655253","Signaling by FGFR2 in disease","17/130","32/2914",1.24127962378168e-15,2.33005917949875e-14,1.39620625351684e-14,"PIK3CA/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/PIK3R1",17
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","20/130","50/2914",3.46378467686641e-15,6.32140703528119e-14,3.78788148873695e-14,"CBL/PIK3CA/FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9/SRC/MAPK3/PIK3R1",20
"R-HSA-5654700","R-HSA-5654700","FRS-mediated FGFR2 signaling","15/130","25/2914",5.5277359940562e-15,9.81546634620249e-14,5.88157400221058e-14,"FGF1/FGF10/FGF16/FGF17/FGF18/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF7/FGF8/FGF9",15
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","16/130","30/2914",8.40037223949179e-15,1.45238014772266e-13,8.70287871903027e-14,"FGFR1/CBL/FGF1/FGF10/FGF17/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF8/FGF9/SRC/MAPK3",16
"R-HSA-1839130","R-HSA-1839130","Signaling by activated point mutants of FGFR3","11/130","12/2914",1.06132917445254e-14,1.65675843243197e-13,9.92754391940328e-14,"FGFR3/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF5/FGF8/FGF9",11
"R-HSA-190239","R-HSA-190239","FGFR3 ligand binding and activation","11/130","12/2914",1.06132917445254e-14,1.65675843243197e-13,9.92754391940328e-14,"FGFR3/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF5/FGF8/FGF9",11
"R-HSA-190372","R-HSA-190372","FGFR3c ligand binding and activation","11/130","12/2914",1.06132917445254e-14,1.65675843243197e-13,9.92754391940328e-14,"FGFR3/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF5/FGF8/FGF9",11
"R-HSA-2033514","R-HSA-2033514","FGFR3 mutant receptor activation","11/130","12/2914",1.06132917445254e-14,1.65675843243197e-13,9.92754391940328e-14,"FGFR3/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF5/FGF8/FGF9",11
"R-HSA-5654710","R-HSA-5654710","PI-3K cascade:FGFR3","13/130","18/2914",1.08433200296156e-14,1.65675843243197e-13,9.92754391940328e-14,"FGFR3/PIK3CA/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF5/FGF8/FGF9/PIK3R1",13
"R-HSA-5654720","R-HSA-5654720","PI-3K cascade:FGFR4","13/130","19/2914",3.30504813278057e-14,4.93503778008372e-13,2.95714832932999e-13,"FGFR4/PIK3CA/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF6/FGF8/FGF9/PIK3R1",13
"R-HSA-5654687","R-HSA-5654687","Downstream signaling of activated FGFR1","15/130","28/2914",5.65007240622681e-14,8.24910571309114e-13,4.94298732147094e-13,"FGFR1/PIK3CA/FGF1/FGF10/FGF17/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF8/FGF9/PIK3R1",15
"R-HSA-190322","R-HSA-190322","FGFR4 ligand binding and activation","11/130","13/2914",6.63940447671807e-14,9.08768487750786e-13,5.44547647871175e-13,"FGFR4/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF6/FGF8/FGF9",11
"R-HSA-190375","R-HSA-190375","FGFR2c ligand binding and activation","11/130","13/2914",6.63940447671807e-14,9.08768487750786e-13,5.44547647871175e-13,"FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF5/FGF6/FGF8/FGF9",11
"R-HSA-5654227","R-HSA-5654227","Phospholipase C-mediated cascade; FGFR3","11/130","13/2914",6.63940447671807e-14,9.08768487750786e-13,5.44547647871175e-13,"FGFR3/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF5/FGF8/FGF9",11
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","14/130","24/2914",8.27956005416276e-14,1.11013692971121e-12,6.65210625189446e-13,"FGFR1/STAT1/STAT3/PIK3CA/FGF1/FGF17/FGF20/FGF23/FGF4/FGF5/FGF6/FGF8/FGF9/PIK3R1",14
"R-HSA-5654688","R-HSA-5654688","SHC-mediated cascade:FGFR1","13/130","21/2914",2.29646333522427e-13,2.97470288916582e-12,1.78248639036773e-12,"FGFR1/FGF1/FGF10/FGF17/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF8/FGF9",13
"R-HSA-1839122","R-HSA-1839122","Signaling by activated point mutants of FGFR1","10/130","11/2914",2.35440715733063e-13,2.97470288916582e-12,1.78248639036773e-12,"FGFR1/FGF1/FGF17/FGF20/FGF23/FGF4/FGF5/FGF6/FGF8/FGF9",10
"R-HSA-190373","R-HSA-190373","FGFR1c ligand binding and activation","10/130","11/2914",2.35440715733063e-13,2.97470288916582e-12,1.78248639036773e-12,"FGFR1/FGF1/FGF17/FGF20/FGF23/FGF4/FGF5/FGF6/FGF8/FGF9",10
"R-HSA-5654228","R-HSA-5654228","Phospholipase C-mediated cascade; FGFR4","11/130","14/2914",2.98195344757684e-13,3.69649700954337e-12,2.21499620535003e-12,"FGFR4/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF6/FGF8/FGF9",11
"R-HSA-5655332","R-HSA-5655332","Signaling by FGFR3 in disease","13/130","22/2914",5.40315002220972e-13,6.45430829925779e-12,3.86751791063433e-12,"FGFR3/PIK3CA/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF5/FGF8/FGF9/PIK3R1",13
"R-HSA-8853338","R-HSA-8853338","Signaling by FGFR3 point mutants in cancer","13/130","22/2914",5.40315002220972e-13,6.45430829925779e-12,3.86751791063433e-12,"FGFR3/PIK3CA/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF5/FGF8/FGF9/PIK3R1",13
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","16/130","37/2914",5.70660495306409e-13,6.69507045386269e-12,4.01178618880821e-12,"FGFR3/CBL/PIK3CA/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF5/FGF8/FGF9/SRC/MAPK3/PIK3R1",16
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","14/130","27/2914",7.55291001414087e-13,8.70572259524658e-12,5.21659897560237e-12,"FGFR3/CBL/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF5/FGF8/FGF9/SRC/MAPK3",14
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","16/130","38/2914",9.4905023673309e-13,1.07504483712697e-11,6.44182919307034e-12,"FGFR4/CBL/PIK3CA/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF6/FGF8/FGF9/SRC/MAPK3/PIK3R1",16
"R-HSA-5654693","R-HSA-5654693","FRS-mediated FGFR1 signaling","13/130","23/2914",1.19613527276198e-12,1.33196758339766e-11,7.98134865322e-12,"FGFR1/FGF1/FGF10/FGF17/FGF20/FGF22/FGF23/FGF3/FGF4/FGF5/FGF6/FGF8/FGF9",13
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","14/130","28/2914",1.4540812787659e-12,1.59221900024867e-11,9.54081400453418e-12,"FGFR4/CBL/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF6/FGF8/FGF9/SRC/MAPK3",14
"R-HSA-5654708","R-HSA-5654708","Downstream signaling of activated FGFR3","13/130","25/2914",5.03689447921247e-12,5.42498307023376e-11,3.25073086320183e-11,"FGFR3/PIK3CA/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF5/FGF8/FGF9/PIK3R1",13
"R-HSA-5658623","R-HSA-5658623","FGFRL1 modulation of FGFR1 signaling","9/130","10/2914",5.1390771683155e-12,5.44576403158594e-11,3.26318312555178e-11,"FGF10/FGF17/FGF18/FGF22/FGF23/FGF3/FGF4/FGF5/FGF8",9
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","14/130","31/2914",8.57291927638331e-12,8.94033010251403e-11,5.35717929718857e-11,"FGFR1/STAT1/STAT3/PIK3CA/FGF1/FGF17/FGF20/FGF23/FGF4/FGF5/FGF6/FGF8/FGF9/PIK3R1",14
"R-HSA-5654716","R-HSA-5654716","Downstream signaling of activated FGFR4","13/130","26/2914",9.69600180546788e-12,9.95355185342562e-11,5.96431690007399e-11,"FGFR4/PIK3CA/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF6/FGF8/FGF9/PIK3R1",13
"R-HSA-5654704","R-HSA-5654704","SHC-mediated cascade:FGFR3","11/130","18/2914",2.23669855848288e-11,2.26078608142039e-10,1.35469677874105e-10,"FGFR3/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF5/FGF8/FGF9",11
"R-HSA-5654719","R-HSA-5654719","SHC-mediated cascade:FGFR4","11/130","19/2914",5.11249474623044e-11,5.08925613374758e-10,3.04955826968132e-10,"FGFR4/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF6/FGF8/FGF9",11
"R-HSA-5654706","R-HSA-5654706","FRS-mediated FGFR3 signaling","11/130","20/2914",1.09340642770905e-10,1.07219107911171e-09,6.42472904891097e-10,"FGFR3/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF5/FGF8/FGF9",11
"R-HSA-5654712","R-HSA-5654712","FRS-mediated FGFR4 signaling","11/130","21/2914",2.20984426102877e-10,2.13509952867044e-09,1.27938351954297e-09,"FGFR4/FGF1/FGF16/FGF17/FGF18/FGF20/FGF23/FGF4/FGF6/FGF8/FGF9",11
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","44/130","397/2914",1.36648416934228e-09,1.30113057863461e-08,7.79656871600325e-09,"CDK5/CREBBP/E2F1/EGFR/EPHA4/FGFR1/MAPK14/MET/RET/RPS6KA3/STAT3/CTNNB1/ERBB2/PIK3CA/EP300/GSK3B/MAP2K1/EFNA1/EFNA2/EFNA3/EFNA4/EFNA5/FGF10/KLF4/FYN/PTK2/SRC/LYN/MAPK3/NOTCH1/PTPRC/CDC42/PIK3R1/PRKCA/RAC1/SMAD2/SMAD3/SMAD4/NFKB1/SOX2/JUN/GATA2/SREBF1/TFDP1",44
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","10/130","25/2914",4.09357679991006e-08,3.84211422505844e-07,2.30225221528776e-07,"CDK5/PIK3CA/BDNF/NTF3/NTF4/FYN/NTRK2/SRC/PIK3R1/RAC1",10
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","9/130","21/2914",9.92436931862617e-08,9.18353611596816e-07,5.50291197207737e-07,"EPHA4/EFNA1/EFNA2/EFNA3/EFNA4/EFNA5/FYN/SRC/LYN",9
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","17/130","92/2914",3.1888580641121e-07,2.90983298350229e-06,1.74361537423673e-06,"FLT4/MAPK14/CTNNB1/PIK3CA/PRKCD/FYN/PTK2/SRC/PGF/CDC42/PIK3R1/PRKCA/RAC1/VEGFA/VEGFB/VEGFC/VEGFD",17
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","44/130","481/2914",5.68310663670932e-07,5.11479597303839e-06,3.06486212275311e-06,"CDK5/CREBBP/E2F1/EGFR/MAPK14/MET/STAT1/CDK1/CTNNB1/ERBB2/AXIN1/CCNE1/EP300/FBXW7/GSK3B/MDM2/TP53/YWHAQ/ESR1/KLF4/BDNF/SRC/MAPK3/NOTCH1/SOCS3/TGFA/E2F4/MAX/PRKAA1/RBL1/SMAD2/SMAD3/SMAD4/VEGFA/MYBL2/JUNB/TCF7/TCF7L2/SOX2/JUN/GATA2/SREBF1/RUNX2/TFDP1",44
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","45/130","499/2914",6.04980792936541e-07,5.37124839134199e-06,3.21853224122712e-06,"CDK5/CREBBP/E2F1/EGFR/MAPK14/MET/STAT1/CDK1/CTNNB1/ERBB2/AXIN1/CCNE1/EP300/FBXW7/GSK3B/MDM2/TP53/YWHAQ/ESR1/KLF4/BDNF/SRC/MAPK3/NOTCH1/SOCS3/TGFA/E2F4/MAX/PRKAA1/RBL1/SMAD2/SMAD3/SMAD4/VEGFA/MYBL2/JUNB/POU2F1/TCF7/TCF7L2/SOX2/JUN/GATA2/SREBF1/RUNX2/TFDP1",45
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","8/130","19/2914",6.32878503135896e-07,5.54401568747045e-06,3.32205698488176e-06,"E2F1/CDK1/CCNE1/E2F4/MAX/RBL1/MYBL2/TFDP1",8
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","11/130","41/2914",9.1982635752275e-07,7.9516568012164e-06,4.76475149187685e-06,"STAT1/STAT3/CBL/PIK3CA/FYN/SRC/LCK/LYN/PIK3R1/PRKCA/RAC1",11
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","16/130","89/2914",1.082135132625e-06,9.23328288486529e-06,5.5327209788346e-06,"CDK5/MAPK14/RPS6KA3/STAT3/PIK3CA/MAP2K1/NGF/BDNF/NTF3/NTF4/FYN/NTRK2/SRC/MAPK3/PIK3R1/RAC1",16
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","6/130","10/2914",1.27559571978382e-06,1.07444408704868e-05,6.43822940889538e-06,"E2F1/CDK1/E2F4/RBL1/MYBL2/TFDP1",6
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","9/130","29/2914",2.49217598301504e-06,2.07260711498846e-05,1.24193713210876e-05,"PDGFRA/PDGFRB/STAT1/STAT3/PIK3CA/PDGFA/PDGFB/SRC/PIK3R1",9
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","7/130","17/2914",4.01078598815267e-06,3.29385799277038e-05,1.97372889416986e-05,"EGFR/AREG/PIK3CA/EREG/SRC/TGFA/PIK3R1",7
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","11/130","49/2914",6.24293540349749e-06,5.06371427172574e-05,3.03425320455888e-05,"PDGFRA/PDGFRB/STAT1/STAT3/PIK3CA/PDGFA/PDGFB/SRC/PDGFC/PDGFD/PIK3R1",11
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","8/130","25/2914",7.21323400561727e-06,5.77938383132993e-05,3.46309309127196e-05,"CREBBP/EGFR/ERBB2/EP300/ESR1/TGFA/VEGFA/MYBL2",8
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","20/130","153/2914",8.50085092398672e-06,6.72898681573406e-05,4.0321093792911e-05,"MAPK14/PIK3CA/PRKCD/IGF2/FYN/PTK2/PDGFA/PDGFB/SRC/LCK/LYN/MAPK3/CDC42/PIK3R1/PRKCA/RAC1/VEGFA/VEGFB/VEGFC/VEGFD",20
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","10/130","42/2914",9.61649191177654e-06,7.52147045956808e-05,4.50697741228625e-05,"EPHA4/EFNA1/EFNA2/EFNA3/EFNA4/EFNA5/FYN/SRC/LYN/RAC1",10
"R-HSA-422475","R-HSA-422475","Axon guidance","27/130","254/2914",1.07722013835222e-05,8.32627801055777e-05,4.98923011447346e-05,"CDK5/EGFR/EPHA4/FGFR1/MAPK14/MET/RET/RPS6KA3/ERBB2/PIK3CA/GSK3B/MAP2K1/EFNA1/EFNA2/EFNA3/EFNA4/EFNA5/FYN/PTK2/SRC/LYN/MAPK3/PTPRC/CDC42/PIK3R1/PRKCA/RAC1",27
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","11/130","53/2914",1.40118170829596e-05,0.000107043765389586,6.41422226319079e-05,"CREBBP/CTNNB1/EP300/MDM2/TP53/SRC/NOTCH1/SMAD3/SMAD4/TCF7/TCF7L2",11
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","16/130","108/2914",1.5089744101896e-05,0.00011395358476949,6.82826895838971e-05,"CREBBP/EGFR/AREG/PIK3CA/AXIN1/EP300/EREG/ESR1/PTK2/SRC/MAPK3/TGFA/PIK3R1/POU2F1/SRF/JUN",16
"R-HSA-1433559","R-HSA-1433559","Regulation of KIT signaling","6/130","15/2914",2.52520520750329e-05,0.00018433998014774,0.000110459268725875,"CBL/FYN/SRC/LCK/LYN/PRKCA",6
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","6/130","15/2914",2.52520520750329e-05,0.00018433998014774,0.000110459268725875,"CDK1/EP300/TP53/E2F4/RBL1/TFDP1",6
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","6/130","15/2914",2.52520520750329e-05,0.00018433998014774,0.000110459268725875,"E2F1/CDK1/CCNE1/E2F4/RBL1/TFDP1",6
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","7/130","22/2914",2.9147793065653e-05,0.000210440659825648,0.000126099185732264,"EGFR/AREG/CBL/PIK3CA/EREG/TGFA/PIK3R1",7
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","12/130","68/2914",3.20826662084588e-05,0.00022818187958693,0.000136729989530581,"EPHA4/EFNA1/EFNA2/EFNA3/EFNA4/EFNA5/FYN/PTK2/SRC/LYN/CDC42/RAC1",12
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","8/130","30/2914",3.2299718115045e-05,0.00022818187958693,0.000136729989530581,"E2F1/CDK1/CCNE1/EP300/TP53/E2F4/RBL1/TFDP1",8
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","7/130","23/2914",4.03566420611156e-05,0.000282067168448435,0.000169018859248121,"CREBBP/E2F1/EP300/TP53/NOTCH1/JUN/TFDP1",7
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","8/130","31/2914",4.19175469213512e-05,0.000289892929761345,0.000173708172283494,"PIK3CA/FYN/SRC/LCK/LYN/CDC42/PIK3R1/RAC1",8
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","7/130","24/2914",5.48763515540067e-05,0.000371688278051365,0.000222721166372203,"E2F4/RBL1/SMAD2/SMAD3/SMAD4/JUNB/TFDP1",7
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","7/130","24/2914",5.48763515540067e-05,0.000371688278051365,0.000222721166372203,"EGFR/AREG/EREG/PTK2/MAPK3/TGFA/SRF",7
"R-HSA-210993","R-HSA-210993","Tie2 Signaling","6/130","17/2914",5.79821824846085e-05,0.000388717284616202,0.000232925201388223,"ANGPT1/TEK/ANGPT2/ANGPT4/PIK3CA/PIK3R1",6
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","5/130","11/2914",6.09216490089059e-05,0.0003924070921456,0.000235136189157181,"E2F1/E2F4/MAX/RBL1/TFDP1",5
"R-HSA-418885","R-HSA-418885","DCC mediated attractive signaling","5/130","11/2914",6.09216490089059e-05,0.0003924070921456,0.000235136189157181,"FYN/PTK2/SRC/CDC42/RAC1",5
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","5/130","11/2914",6.09216490089059e-05,0.0003924070921456,0.000235136189157181,"STAT3/KLF4/SMAD2/SMAD4/SOX2",5
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","5/130","11/2914",6.09216490089059e-05,0.0003924070921456,0.000235136189157181,"EGFR/ERBB2/ESR1/TGFA/VEGFA",5
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","11/130","63/2914",7.71785841479772e-05,0.000491206667787878,0.000294338370187722,"EGFR/AREG/PIK3CA/EREG/ESR1/PTK2/SRC/MAPK3/TGFA/PIK3R1/SRF",11
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","17/130","136/2914",7.77556977929062e-05,0.000491206667787878,0.000294338370187722,"CREBBP/EGFR/AREG/PIK3CA/AXIN1/EP300/EREG/ESR1/PTK2/SRC/MAPK3/TGFA/PIK3R1/POU2F1/SRF/JUN/SREBF1",17
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","9/130","44/2914",9.96462717292181e-05,0.000617618872887701,0.000370086451109509,"EGFR/ERBB2/PIK3CA/PRKCD/EREG/FYN/SRC/PIK3R1/PRKCA",9
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","9/130","44/2914",9.96462717292181e-05,0.000617618872887701,0.000370086451109509,"EGFR/AREG/CBL/PIK3CA/EREG/SRC/TGFA/CDC42/PIK3R1",9
"R-HSA-114604","R-HSA-114604","GPVI-mediated activation cascade","7/130","28/2914",0.000161600356507194,0.000992256394628282,0.000594574848339306,"PIK3CA/FYN/LCK/LYN/CDC42/PIK3R1/RAC1",7
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","9/130","47/2914",0.000170886420270784,0.00103002181759546,0.000617204453706162,"EGFR/STAT3/CBL/ERBB2/CCNE1/EREG/SOCS3/RAC1/HIF1A",9
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","9/130","47/2914",0.000170886420270784,0.00103002181759546,0.000617204453706162,"EGFR/STAT3/CBL/ERBB2/CCNE1/EREG/SOCS3/RAC1/HIF1A",9
"R-HSA-109582","R-HSA-109582","Hemostasis","27/130","298/2914",0.000192242145656548,0.00114820990633047,0.00068802452129712,"ANGPT1/CDK5/MAPK14/TEK/ANGPT2/ANGPT4/PIK3CA/PRKCD/TP53/IGF2/FYN/PTK2/PDGFA/PDGFB/SRC/LCK/LYN/MAPK3/CDC42/PIK3R1/PRKCA/RAC1/VEGFA/VEGFB/VEGFC/VEGFD/GATA2",27
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","7/130","29/2914",0.000205191268353504,0.00121451048025452,0.000727752815212995,"CREBBP/E2F1/EP300/TP53/NOTCH1/JUN/TFDP1",7
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","12/130","85/2914",0.0003020240268867,0.00177169451486216,0.00106162580879347,"MAPK14/CTNNB1/PIK3CA/PRKCD/FYN/PTK2/SRC/CDC42/PIK3R1/PRKCA/RAC1/VEGFA",12
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","10/130","62/2914",0.000327361630959382,0.00190333266849836,0.00114050535611373,"PIK3CA/PRKCD/FYN/PTK2/SRC/LYN/MAPK3/CDC42/PIK3R1/RAC1",10
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","10/130","63/2914",0.000374565979414364,0.00215868288136173,0.00129351501662947,"CBL/E2F4/PARD6A/RBL1/SMAD2/SMAD3/SMAD4/TGFBR1/JUNB/TFDP1",10
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","6/130","23/2914",0.00037887664322199,0.00216453873562476,0.0012970239319453,"E2F1/MDM2/TP53/MAPK3/ETS1/TFDP1",6
"R-HSA-1963642","R-HSA-1963642","PI3K events in ERBB2 signaling","5/130","16/2914",0.000480559168323683,0.00269852456058684,0.00161699621190335,"EGFR/ERBB2/PIK3CA/EREG/PIK3R1",5
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","5/130","16/2914",0.000480559168323683,0.00269852456058684,0.00161699621190335,"MAPK14/PRKCD/MAPK3/PRKCA/RAC1",5
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","13/130","104/2914",0.000573405073905692,0.0031926028267461,0.0019130552867148,"CREBBP/E2F1/EGFR/FLT4/STAT1/EP300/FBXW7/TP53/NOTCH1/SMAD3/HIF1A/JUN/TFDP1",13
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","5/130","17/2914",0.000656632912423297,0.00362527582741266,0.00217231940952068,"CREBBP/FLT4/EP300/NOTCH1/SMAD3",5
"R-HSA-182971","R-HSA-182971","EGFR downregulation","6/130","26/2914",0.000773649117462028,0.0042357289181046,0.00253811201693683,"EGFR/AREG/CBL/EREG/TGFA/CDC42",6
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","10/130","69/2914",0.000792810128659565,0.00430476243412673,0.00257947793056701,"ANGPT1/TEK/ANGPT2/ANGPT4/PIK3CA/FYN/SRC/LCK/LYN/PIK3R1",10
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","7/130","36/2914",0.000844834850292696,0.00454964341510083,0.0027262142710049,"E2F4/RBL1/SMAD2/SMAD3/SMAD4/JUNB/TFDP1",7
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","10/130","70/2914",0.000890370319575997,0.0047558804874913,0.00284979460437675,"MAPK14/RPS6KA3/STAT3/PIK3CA/MAP2K1/NGF/NTRK2/SRC/MAPK3/PIK3R1",10
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","4/130","11/2914",0.000977751442823363,0.0051390615834796,0.00307940243887106,"STAT1/STAT3/CBL/SOCS3",4
"R-HSA-210990","R-HSA-210990","PECAM1 interactions","4/130","11/2914",0.000977751442823363,0.0051390615834796,0.00307940243887106,"FYN/SRC/LCK/LYN",4
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","5/130","19/2914",0.00114798455778913,0.00598591947990046,0.00358685233594933,"CREBBP/EP300/FYN/LYN/NFKB1",5
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","7/130","38/2914",0.00118544426963268,0.00613257389880844,0.00367472985364793,"CDK5/MET/ERBB2/GSK3B/FYN/PTPRC/RAC1",7
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","8/130","49/2914",0.00121482653304626,0.00623547681415149,0.00373639081709951,"CREBBP/EP300/YWHAQ/KLF4/SMAD2/SMAD3/SMAD4/SREBF1",8
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","12/130","99/2914",0.00124087197087205,0.00631978980513906,0.0037869124202868,"E2F1/MAPK14/RPS6KA3/STAT3/CCNE1/MDM2/TP53/MAPK3/NFKB1/JUN/ETS1/TFDP1",12
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","18/130","187/2914",0.00129489121890251,0.0065441810062996,0.00392137097870071,"CREBBP/E2F1/MAPK14/RPS6KA3/STAT3/CCNE1/EP300/GSK3B/MDM2/TP53/MAPK3/VEGFA/ARNT/NFKB1/HIF1A/JUN/ETS1/TFDP1",18
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","4/130","12/2914",0.0014162695856795,0.00704915998326842,0.00422396192220202,"STAT1/STAT3/PIK3CA/PIK3R1",4
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","4/130","12/2914",0.0014162695856795,0.00704915998326842,0.00422396192220202,"FYN/LCK/CDC42/RAC1",4
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","9/130","62/2914",0.00143997982760078,0.0071132838100279,0.00426238587671303,"STAT1/CDK1/FBXW7/GSK3B/ESR1/SRC/MAPK3/SMAD4/RUNX2",9
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","18/130","189/2914",0.00146562825297987,0.00713267023269703,0.0042740025106604,"CREBBP/E2F1/MAPK14/RPS6KA3/STAT3/CCNE1/EP300/GSK3B/MDM2/TP53/MAPK3/VEGFA/ARNT/NFKB1/HIF1A/JUN/ETS1/TFDP1",18
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","5/130","20/2914",0.00147647359459177,0.00713267023269703,0.0042740025106604,"EGFR/FGFR1/MAP2K1/MAPK3/RAC1",5
"R-HSA-912631","R-HSA-912631","Regulation of signaling by CBL","5/130","20/2914",0.00147647359459177,0.00713267023269703,0.0042740025106604,"CBL/PIK3CA/FYN/LYN/PIK3R1",5
"R-HSA-400253","R-HSA-400253","Circadian Clock","8/130","52/2914",0.00181086847211921,0.00868423785534543,0.00520372499863685,"CREBBP/CSNK1D/EP300/PER2/CLOCK/CREM/HIF1A/SREBF1",8
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","10/130","77/2914",0.00188614635255136,0.00897969676540757,0.00538076838942951,"E2F1/CDK1/CCNE1/SRC/LYN/E2F4/MAX/RBL1/MYBL2/TFDP1",10
"R-HSA-179812","R-HSA-179812","GRB2 events in EGFR signaling","4/130","13/2914",0.00197557414096029,0.00933778568784828,0.00559534061885005,"EGFR/AREG/EREG/TGFA",4
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","8/130","53/2914",0.00205413439494163,0.00963975926769037,0.00577628769705391,"PIK3CA/FYN/SRC/LCK/LYN/CDC42/PIK3R1/RAC1",8
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","5/130","22/2914",0.00233369718557775,0.0107974581051027,0.00646999812754692,"EGFR/ERBB2/PRKCD/EREG/PRKCA",5
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","5/130","22/2914",0.00233369718557775,0.0107974581051027,0.00646999812754692,"CREBBP/CTNNB1/EP300/TCF7/TCF7L2",5
"R-HSA-180336","R-HSA-180336","SHC1 events in EGFR signaling","4/130","14/2914",0.00267108988834928,0.0120199044975718,0.00720250625986036,"EGFR/AREG/EREG/TGFA",4
"R-HSA-5637810","R-HSA-5637810","Constitutive Signaling by EGFRvIII","4/130","14/2914",0.00267108988834928,0.0120199044975718,0.00720250625986036,"EGFR/CBL/PIK3CA/PIK3R1",4
"R-HSA-5637812","R-HSA-5637812","Signaling by EGFRvIII in Cancer","4/130","14/2914",0.00267108988834928,0.0120199044975718,0.00720250625986036,"EGFR/CBL/PIK3CA/PIK3R1",4
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","4/130","14/2914",0.00267108988834928,0.0120199044975718,0.00720250625986036,"KLF4/SMAD2/SMAD3/SMAD4",4
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","7/130","44/2914",0.00287910396778902,0.0128678320193019,0.00771059709239594,"E2F1/MAPK14/MDM2/TP53/MAPK3/JUN/TFDP1",7
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","13/130","124/2914",0.00298535316964441,0.0132525475165971,0.00794112436306549,"TNIP2/CDK1/AXIN1/EP300/MDM2/TP53/ESR1/MAP3K7/SMAD2/SMAD3/SMAD4/TGFBR1/HIF1A",13
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","6/130","34/2914",0.00336881671437735,0.0148544468546706,0.00890100636649332,"FYN/PTK2/SRC/LYN/CDC42/RAC1",6
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","5/130","24/2914",0.00350560451056217,0.0149110653800362,0.00893493303233765,"CREBBP/EP300/VEGFA/ARNT/HIF1A",5
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","5/130","24/2914",0.00350560451056217,0.0149110653800362,0.00893493303233765,"PIK3CA/FYN/LCK/PIK3R1/RAC1",5
"R-HSA-2424491","R-HSA-2424491","DAP12 signaling","5/130","24/2914",0.00350560451056217,0.0149110653800362,0.00893493303233765,"PIK3CA/FYN/LCK/PIK3R1/RAC1",5
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","5/130","24/2914",0.00350560451056217,0.0149110653800362,0.00893493303233765,"STAT1/STAT3/LYN/MAPK3/SOCS3",5
"R-HSA-2730905","R-HSA-2730905","Role of LAT2/NTAL/LAB on calcium mobilization","4/130","15/2914",0.00351783125404203,0.0149110653800362,0.00893493303233765,"PIK3CA/FYN/LYN/PIK3R1",4
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","4/130","15/2914",0.00351783125404203,0.0149110653800362,0.00893493303233765,"MET/CBL/CTNNB1/SRC",4
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","6/130","35/2914",0.00391965325112608,0.0165077704230117,0.00989170253657998,"MAPK14/FYN/PTK2/SRC/CDC42/RAC1",6
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","17/130","191/2914",0.00412127592255803,0.0172108887780967,0.0103130215541267,"E2F1/CDK1/CCNE1/CSNK1D/EP300/GSK3B/TP53/SRC/LYN/MAPK3/E2F4/MAX/PRKCA/RBL1/MYBL2/FOXM1/TFDP1",17
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","9/130","72/2914",0.00413899608362143,0.0172108887780967,0.0103130215541267,"CREBBP/PRKCD/EP300/FYN/SRC/LYN/MAP3K7/NFKB1/NFATC1",9
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","10/130","86/2914",0.00432443360603251,0.0178688860324739,0.0107073033343671,"CBL/E2F4/PARD6A/RBL1/SMAD2/SMAD3/SMAD4/TGFBR1/JUNB/TFDP1",10
"R-HSA-1236382","R-HSA-1236382","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","4/130","16/2914",0.00453025528261481,0.0183727019794934,0.0110091973729561,"EGFR/CBL/PIK3CA/PIK3R1",4
"R-HSA-5637815","R-HSA-5637815","Signaling by Ligand-Responsive EGFR Variants in Cancer","4/130","16/2914",0.00453025528261481,0.0183727019794934,0.0110091973729561,"EGFR/CBL/PIK3CA/PIK3R1",4
"R-HSA-9034015","R-HSA-9034015","Signaling by NTRK3 (TRKC)","4/130","16/2914",0.00453025528261481,0.0183727019794934,0.0110091973729561,"PIK3CA/NTF3/SRC/PIK3R1",4
"R-HSA-450294","R-HSA-450294","MAP kinase activation","8/130","60/2914",0.00456006552796075,0.0183801414225166,0.0110136551983036,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","10/130","87/2914",0.00470403252996208,0.018844813245031,0.011292093492977,"PIK3CA/FYN/LYN/MAPK3/MAP3K7/PIK3R1/RAC1/NFKB1/JUN/NFATC1",10
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","5/130","26/2914",0.00505002435367858,0.0200844368266183,0.0120348944535052,"STAT1/FBXW7/GSK3B/ESR1/RUNX2",5
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","25/130","332/2914",0.00507460656502077,0.0200844368266183,0.0120348944535052,"MAPK14/RPS6KA3/STAT1/STAT3/TNIP2/CBL/PIK3CA/MAP2K1/TP53/FYN/LCK/LYN/MAPK3/SOCS3/CDC42/MAP3K7/PIK3R1/SMAD3/VEGFA/NFKB1/JUNB/POU2F1/SOX2/HIF1A/JUN",25
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","7/130","49/2914",0.0053608127621902,0.0210901436213112,0.0126375289824087,"CREBBP/AXIN1/EP300/ESR1/TGFA/POU2F1/JUN",7
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","8/130","62/2914",0.00559101848201013,0.0217354978856844,0.0130242348942497,"MET/STAT3/CBL/PIK3CA/PTK2/SRC/PIK3R1/RAC1",8
"R-HSA-76005","R-HSA-76005","Response to elevated platelet cytosolic Ca2+","8/130","62/2914",0.00559101848201013,0.0217354978856844,0.0130242348942497,"IGF2/PDGFA/PDGFB/PRKCA/VEGFA/VEGFB/VEGFC/VEGFD",8
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","9/130","76/2914",0.0059573438974187,0.0229752567954236,0.0137671169454273,"CTNNB1/DVL1/MAP3K7/PARD6A/PRKCA/RAC1/TCF7/TCF7L2/NFATC1",9
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","5/130","27/2914",0.005979861357713,0.0229752567954236,0.0137671169454273,"E2F1/STAT3/EP300/GATA2/TFDP1",5
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","8/130","64/2914",0.00679135830062727,0.0259414093227449,0.0155444798313011,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","5/130","28/2914",0.00702414781030955,0.0266755208749906,0.0159843704353865,"CBL/SMAD2/SMAD3/SMAD4/TGFBR1",5
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","4/130","18/2914",0.00710647930430333,0.0266797537310131,0.0159869068259215,"EGFR/RPS6KA3/MAPK3/PRKCA",4
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","4/130","18/2914",0.00710647930430333,0.0266797537310131,0.0159869068259215,"CREBBP/STAT1/EP300/NOTCH1",4
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","6/130","40/2914",0.0077216560096593,0.0283414971974646,0.0169826483246844,"CTNNB1/MAP3K7/PRKCA/TCF7/TCF7L2/NFATC1",6
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","6/130","40/2914",0.0077216560096593,0.0283414971974646,0.0169826483246844,"E2F1/SRC/LYN/E2F4/RBL1/TFDP1",6
"R-HSA-69236","R-HSA-69236","G1 Phase","6/130","40/2914",0.0077216560096593,0.0283414971974646,0.0169826483246844,"E2F1/SRC/LYN/E2F4/RBL1/TFDP1",6
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","6/130","40/2914",0.0077216560096593,0.0283414971974646,0.0169826483246844,"CREBBP/FLT4/EP300/FBXW7/NOTCH1/SMAD3",6
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","10/130","94/2914",0.00815193203705828,0.0293016367276963,0.0175579782682983,"STAT1/STAT3/TP53/SOCS3/PIK3R1/VEGFA/JUNB/POU2F1/SOX2/HIF1A",10
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","3/130","10/2914",0.00826776243043321,0.0293016367276963,0.0175579782682983,"CDK1/MAP2K1/MAPK3",3
"R-HSA-1250342","R-HSA-1250342","PI3K events in ERBB4 signaling","3/130","10/2914",0.00826776243043321,0.0293016367276963,0.0175579782682983,"PIK3CA/EREG/PIK3R1",3
"R-HSA-2029481","R-HSA-2029481","FCGR activation","3/130","10/2914",0.00826776243043321,0.0293016367276963,0.0175579782682983,"FYN/SRC/LYN",3
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","3/130","10/2914",0.00826776243043321,0.0293016367276963,0.0175579782682983,"MAPK14/MAPK3/JUN",3
"R-HSA-8853334","R-HSA-8853334","Signaling by FGFR3 fusions in cancer","3/130","10/2914",0.00826776243043321,0.0293016367276963,0.0175579782682983,"FGFR3/PIK3CA/PIK3R1",3
"R-HSA-373760","R-HSA-373760","L1CAM interactions","7/130","53/2914",0.00829559502031494,0.0293016367276963,0.0175579782682983,"EGFR/FGFR1/RPS6KA3/MAP2K1/SRC/MAPK3/RAC1",7
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","9/130","80/2914",0.00834003967744171,0.0293016367276963,0.0175579782682983,"AXIN1/MDM2/TP53/MAP3K7/SMAD2/SMAD3/SMAD4/TGFBR1/HIF1A",9
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","4/130","19/2914",0.00869541123670711,0.0300678167500872,0.018017084778551,"FYN/SRC/LCK/LYN",4
"R-HSA-5218921","R-HSA-5218921","VEGFR2 mediated cell proliferation","4/130","19/2914",0.00869541123670711,0.0300678167500872,0.018017084778551,"PRKCD/SRC/PRKCA/VEGFA",4
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","4/130","19/2914",0.00869541123670711,0.0300678167500872,0.018017084778551,"SMAD2/SMAD3/SMAD4/SREBF1",4
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","3/130","11/2914",0.0110015165507869,0.0370666480711129,0.0222108890148141,"E2F1/CDK1/TFDP1",3
"R-HSA-5655291","R-HSA-5655291","Signaling by FGFR4 in disease","3/130","11/2914",0.0110015165507869,0.0370666480711129,0.0222108890148141,"FGFR4/PIK3CA/PIK3R1",3
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","3/130","11/2914",0.0110015165507869,0.0370666480711129,0.0222108890148141,"E2F1/CCNE1/TP53",3
"R-HSA-9027276","R-HSA-9027276","Erythropoietin activates Phosphoinositide-3-kinase (PI3K)","3/130","11/2914",0.0110015165507869,0.0370666480711129,0.0222108890148141,"PIK3CA/LYN/PIK3R1",3
"R-HSA-9028731","R-HSA-9028731","Activated NTRK2 signals through FRS2 and FRS3","3/130","11/2914",0.0110015165507869,0.0370666480711129,0.0222108890148141,"BDNF/NTF4/NTRK2",3
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","12/130","130/2914",0.0118226174560171,0.0396298962683838,0.0237468256098302,"MAPK14/CTNNB1/PRKCD/DVL1/YWHAQ/PTK2/SRC/MAPK3/CDC42/PRKCA/RAC1/SRF",12
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","7/130","57/2914",0.0122744549538498,0.0407350545300556,0.0244090529427875,"CTNNB1/PIK3CA/FYN/PTK2/SRC/PARD6A/PIK3R1",7
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","6/130","44/2914",0.0122763178035784,0.0407350545300556,0.0244090529427875,"EGFR/PIK3CA/EREG/ESR1/SRC/PIK3R1",6
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","5/130","32/2914",0.0124791994277637,0.0409592798311151,0.0245434120913836,"FGFR1/FYN/PTK2/SRC/MAPK3",5
"R-HSA-8853659","R-HSA-8853659","RET signaling","5/130","32/2914",0.0124791994277637,0.0409592798311151,0.0245434120913836,"RET/PIK3CA/SRC/PIK3R1/PRKCA",5
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","4/130","21/2914",0.0125309212268708,0.0409592798311151,0.0245434120913836,"PIK3CA/FYN/LCK/PIK3R1",4
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","19/130","249/2914",0.0128858824969167,0.0419110138637339,0.0251137053353144,"E2F1/CDK1/CCNE1/CSNK1D/EP300/GSK3B/MDM2/TP53/YWHAQ/SRC/LYN/MAPK3/E2F4/MAX/PRKCA/RBL1/MYBL2/FOXM1/TFDP1",19
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","5/130","33/2914",0.0141937267259664,0.0450587703344229,0.0269998880158202,"MAPK14/MAP2K1/NGF/SRC/MAPK3",5
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","3/130","12/2914",0.0141965988724894,0.0450587703344229,0.0269998880158202,"SMAD2/SMAD3/SMAD4",3
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","3/130","12/2914",0.0141965988724894,0.0450587703344229,0.0269998880158202,"MAP2K1/NGF/MAPK3",3
"R-HSA-204005","R-HSA-204005","COPII-mediated vesicle transport","3/130","12/2914",0.0141965988724894,0.0450587703344229,0.0269998880158202,"AREG/CSNK1D/TGFA",3
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","3/130","12/2914",0.0141965988724894,0.0450587703344229,0.0269998880158202,"CREBBP/EP300/NOTCH1",3
"R-HSA-114608","R-HSA-114608","Platelet degranulation ","7/130","59/2914",0.014712555002674,0.0464718684459463,0.0278466375050612,"IGF2/PDGFA/PDGFB/VEGFA/VEGFB/VEGFC/VEGFD",7
"R-HSA-69206","R-HSA-69206","G1/S Transition","7/130","60/2914",0.0160534498389569,0.0502451403444842,0.030107638370323,"E2F1/CDK1/CCNE1/E2F4/MAX/RBL1/TFDP1",7
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","5/130","34/2914",0.016060090521068,0.0502451403444842,0.030107638370323,"CREBBP/PRKDC/CTNNB1/EP300/NFKB1",5
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","4/130","23/2914",0.01730650114478,0.0538345386872014,0.0322584594552805,"STAT1/STAT3/CBL/SOCS3",4
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","3/130","13/2914",0.0178629062919481,0.0538345386872014,0.0322584594552805,"CREBBP/EP300/SREBF1",3
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","3/130","13/2914",0.0178629062919481,0.0538345386872014,0.0322584594552805,"MAP2K1/NGF/MAPK3",3
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","3/130","13/2914",0.0178629062919481,0.0538345386872014,0.0322584594552805,"GSK3A/GSK3B/MDM2",3
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","3/130","13/2914",0.0178629062919481,0.0538345386872014,0.0322584594552805,"CTNNB1/CDC42/RAC1",3
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","3/130","13/2914",0.0178629062919481,0.0538345386872014,0.0322584594552805,"EP300/MDM2/TP53",3
"R-HSA-8847993","R-HSA-8847993","ERBB2 Activates PTK6 Signaling","3/130","13/2914",0.0178629062919481,0.0538345386872014,0.0322584594552805,"EGFR/ERBB2/EREG",3
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","3/130","13/2914",0.0178629062919481,0.0538345386872014,0.0322584594552805,"CREBBP/EP300/NOTCH1",3
"R-HSA-195721","R-HSA-195721","Signaling by WNT","14/130","172/2914",0.0191756188411421,0.0575268565234263,0.0344709514375734,"CREBBP/CTNNB1/AXIN1/DVL1/EP300/GSK3B/MAP3K7/PARD6A/PRKCA/RAC1/TCF7/TCF7L2/SOX2/NFATC1",14
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","4/130","24/2914",0.0200666804716236,0.0596552446599851,0.0357463133907465,"CREBBP/EP300/FGF10/NOTCH1",4
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","4/130","24/2914",0.0200666804716236,0.0596552446599851,0.0357463133907465,"SRC/MAPK3/SMAD4/RUNX2",4
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","6/130","49/2914",0.0202854301069368,0.0600339080191778,0.0359732141298926,"E2F1/STAT3/TP53/YWHAQ/MAPK3/TFDP1",6
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","8/130","78/2914",0.0213467848911966,0.061523517951026,0.0368658106443703,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","8/130","78/2914",0.0213467848911966,0.061523517951026,0.0368658106443703,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","8/130","78/2914",0.0213467848911966,0.061523517951026,0.0368658106443703,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","3/130","14/2914",0.0220061289474751,0.061523517951026,0.0368658106443703,"CBL/SRC/MAPK3",3
"R-HSA-373753","R-HSA-373753","Nephrin family interactions","3/130","14/2914",0.0220061289474751,0.061523517951026,0.0368658106443703,"PIK3CA/FYN/PIK3R1",3
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","3/130","14/2914",0.0220061289474751,0.061523517951026,0.0368658106443703,"CTNNB1/AXIN1/GSK3B",3
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","3/130","14/2914",0.0220061289474751,0.061523517951026,0.0368658106443703,"CTNNB1/AXIN1/GSK3B",3
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","3/130","14/2914",0.0220061289474751,0.061523517951026,0.0368658106443703,"CTNNB1/AXIN1/GSK3B",3
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","3/130","14/2914",0.0220061289474751,0.061523517951026,0.0368658106443703,"CTNNB1/AXIN1/GSK3B",3
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","3/130","14/2914",0.0220061289474751,0.061523517951026,0.0368658106443703,"CTNNB1/AXIN1/GSK3B",3
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","3/130","14/2914",0.0220061289474751,0.061523517951026,0.0368658106443703,"CTNNB1/AXIN1/GSK3B",3
"R-HSA-5684264","R-HSA-5684264","MAP3K8 (TPL2)-dependent MAPK1/3 activation","3/130","14/2914",0.0220061289474751,0.061523517951026,0.0368658106443703,"TNIP2/MAP2K1/NFKB1",3
"R-HSA-6785631","R-HSA-6785631","ERBB2 Regulates Cell Motility","3/130","14/2914",0.0220061289474751,0.061523517951026,0.0368658106443703,"EGFR/ERBB2/EREG",3
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","5/130","37/2914",0.0226204876103244,0.0627074276792537,0.037575227032029,"CTNNB1/AXIN1/GSK3B/TCF7/TCF7L2",5
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","5/130","37/2914",0.0226204876103244,0.0627074276792537,0.037575227032029,"CREBBP/EGFR/STAT1/EP300/NOTCH1",5
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","4/130","25/2914",0.0230836397042071,0.0637224843935466,0.0381834641723727,"PTK2/MAPK3/CDC42/RAC1",4
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","15/130","194/2914",0.0237641986966967,0.0653266884674885,0.0391447272079479,"CDK5/CREBBP/E2F1/MAPK14/CDK1/CCNE1/EP300/MDM2/TP53/YWHAQ/E2F4/PRKAA1/RBL1/JUN/TFDP1",15
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","3/130","15/2914",0.0266282033708333,0.0725922390648859,0.0434983536173473,"SMAD2/SMAD3/SMAD4",3
"R-HSA-400685","R-HSA-400685","Sema4D in semaphorin signaling","3/130","15/2914",0.0266282033708333,0.0725922390648859,0.0434983536173473,"MET/ERBB2/RAC1",3
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","5/130","39/2914",0.0278390551344846,0.0755795835675883,0.0452884150513146,"E2F1/CCNE1/E2F4/MAX/TFDP1",5
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","8/130","83/2914",0.0298300787285875,0.0805290336473712,0.0482541994458333,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","4/130","27/2914",0.0299072819025245,0.0805290336473712,0.0482541994458333,"TNIP2/CDK1/TP53/ESR1",4
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","7/130","68/2914",0.0300393702280463,0.0805545560809241,0.048269492869127,"E2F1/CDK1/CSNK1D/EP300/TP53/MYBL2/FOXM1",7
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","5/130","40/2914",0.0307129692951739,0.0813646001085857,0.0487548833463287,"CREBBP/EP300/FBXW7/NOTCH1/HIF1A",5
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","5/130","40/2914",0.0307129692951739,0.0813646001085857,0.0487548833463287,"CREBBP/EP300/KLF4/NFKB1/SREBF1",5
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","5/130","40/2914",0.0307129692951739,0.0813646001085857,0.0487548833463287,"E2F1/CCNE1/E2F4/MAX/TFDP1",5
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","3/130","16/2914",0.0317277298527299,0.0821798800323618,0.0492434112506662,"CTNNB1/AXIN1/GSK3B",3
"R-HSA-1963640","R-HSA-1963640","GRB2 events in ERBB2 signaling","3/130","16/2914",0.0317277298527299,0.0821798800323618,0.0492434112506662,"EGFR/ERBB2/EREG",3
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","3/130","16/2914",0.0317277298527299,0.0821798800323618,0.0492434112506662,"FYN/SRC/RAC1",3
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","3/130","16/2914",0.0317277298527299,0.0821798800323618,0.0492434112506662,"EP300/MDM2/SRC",3
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","8/130","84/2914",0.0317712169379298,0.0821798800323618,0.0492434112506662,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","8/130","84/2914",0.0317712169379298,0.0821798800323618,0.0492434112506662,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","5/130","41/2914",0.033767322510876,0.0870005132927275,0.0521320066834577,"STAT1/STAT3/PIK3CA/LCK/PIK3R1",5
"R-HSA-109581","R-HSA-109581","Apoptosis","9/130","101/2914",0.0341642712516881,0.0876793992670278,0.0525388052965928,"E2F1/STAT3/CTNNB1/PRKCD/TP53/YWHAQ/PTK2/MAPK3/TFDP1",9
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","8/130","86/2914",0.0359104718548761,0.0907430000332831,0.054374560622363,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","8/130","86/2914",0.0359104718548761,0.0907430000332831,0.054374560622363,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","8/130","86/2914",0.0359104718548761,0.0907430000332831,0.054374560622363,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","8/130","86/2914",0.0359104718548761,0.0907430000332831,0.054374560622363,"CREBBP/AXIN1/EP300/ESR1/SRC/SOCS3/GATA2/RUNX2",8
"R-HSA-164952","R-HSA-164952","The role of Nef in HIV-1 replication and disease pathogenesis","3/130","17/2914",0.0373003564449947,0.0935356266578684,0.0560479441961752,"FYN/LCK/RAC1",3
"R-HSA-2029485","R-HSA-2029485","Role of phospholipids in phagocytosis","3/130","17/2914",0.0373003564449947,0.0935356266578684,0.0560479441961752,"PIK3CA/PRKCD/PIK3R1",3
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","4/130","29/2914",0.0378061655417013,0.093779746530974,0.0561942244694132,"E2F1/TP53/YWHAQ/TFDP1",4
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","9/130","103/2914",0.0381048548943494,0.093779746530974,0.0561942244694132,"E2F1/STAT3/CTNNB1/PRKCD/TP53/YWHAQ/PTK2/MAPK3/TFDP1",9
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","8/130","87/2914",0.0381114038413547,0.093779746530974,0.0561942244694132,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","8/130","87/2914",0.0381114038413547,0.093779746530974,0.0561942244694132,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","8/130","87/2914",0.0381114038413547,0.093779746530974,0.0561942244694132,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","5/130","43/2914",0.0404269532869358,0.0991063742892418,0.0593860193610133,"PIK3CA/LCK/MAP3K7/PIK3R1/NFKB1",5
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","4/130","30/2914",0.0421635468492445,0.101843567205712,0.0610261862291697,"LYN/MAPK3/RAC1/JUN",4
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","4/130","30/2914",0.0421635468492445,0.101843567205712,0.0610261862291697,"STAT3/CCNE1/FBXW7/TP53",4
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","4/130","30/2914",0.0421635468492445,0.101843567205712,0.0610261862291697,"MAPK14/RPS6KA3/MAPK3/JUN",4
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","4/130","30/2914",0.0421635468492445,0.101843567205712,0.0610261862291697,"CTNNB1/AXIN1/DVL1/GSK3B",4
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","3/130","18/2914",0.0433391318731329,0.104299669013364,0.0624979191075833,"E2F1/MAX/TFDP1",3
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","8/130","90/2914",0.0452547201935939,0.108117640607968,0.0647857046981976,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","8/130","90/2914",0.0452547201935939,0.108117640607968,0.0647857046981976,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-202403","R-HSA-202403","TCR signaling","6/130","59/2914",0.045585577241284,0.108513493650448,0.065022905752251,"PIK3CA/LCK/PTPRC/MAP3K7/PIK3R1/NFKB1",6
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","4/130","31/2914",0.0467935582709598,0.110191282380002,0.0660282618122579,"CTNNB1/TCF7/TCF7L2/SOX2",4
"R-HSA-391251","R-HSA-391251","Protein folding","4/130","31/2914",0.0467935582709598,0.110191282380002,0.0660282618122579,"STAT3/CCNE1/FBXW7/TP53",4
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","4/130","31/2914",0.0467935582709598,0.110191282380002,0.0660282618122579,"CTNNB1/AXIN1/GSK3B/TCF7L2",4
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","5/130","45/2914",0.0478330628053505,0.111837445776211,0.067014667500285,"RPS6KA3/STAT3/MAPK3/NFKB1/JUN",5
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","5/130","45/2914",0.0478330628053505,0.111837445776211,0.067014667500285,"CBL/PIK3CA/FYN/LYN/PIK3R1",5
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","9/130","108/2914",0.0492924612323636,0.114840946913698,0.0688144102310713,"CREBBP/CTNNB1/AXIN1/DVL1/EP300/GSK3B/TCF7/TCF7L2/SOX2",9
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","3/130","19/2914",0.0498348294924628,0.115694286136212,0.0693257438355257,"SRC/MAPK3/RUNX2",3
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","7/130","77/2914",0.0536521399834799,0.124117802708262,0.0743732407480411,"RPS6KA3/MDM2/SRC/MAPK3/PRKAA1/PRKCA/RAC1",7
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","5/130","47/2914",0.0559942523163939,0.128181964361919,0.076808547098226,"CREBBP/EP300/CLOCK/ARNT/SREBF1",5
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","5/130","47/2914",0.0559942523163939,0.128181964361919,0.076808547098226,"RPS6KA3/SRC/MAPK3/PRKAA1/RAC1",5
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","5/130","47/2914",0.0559942523163939,0.128181964361919,0.076808547098226,"DVL1/SRC/CDC42/RAC1/SRF",5
"R-HSA-167044","R-HSA-167044","Signalling to RAS","3/130","20/2914",0.0567762442886794,0.128627560336767,0.077075554860131,"MAPK14/NGF/SRC",3
"R-HSA-199977","R-HSA-199977","ER to Golgi Anterograde Transport","3/130","20/2914",0.0567762442886794,0.128627560336767,0.077075554860131,"AREG/CSNK1D/TGFA",3
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","3/130","20/2914",0.0567762442886794,0.128627560336767,0.077075554860131,"SMAD2/SMAD3/SMAD4",3
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","6/130","63/2914",0.0595707594213455,0.134494807353347,0.0805912968840051,"FYN/LYN/MAP3K7/PIK3R1/NFKB1/NFATC1",6
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","5/130","48/2914",0.0603589414296636,0.135807618216743,0.0813779527566481,"CREBBP/EP300/CLOCK/ARNT/SREBF1",5
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","4/130","34/2914",0.062309375358942,0.139717609593259,0.0837208779746517,"CDK1/CDC42/RAC1/JUN",4
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","3/130","21/2914",0.0641504647989808,0.142870696179425,0.0856102545399422,"CTNNB1/PRKCD/PTK2",3
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","3/130","21/2914",0.0641504647989808,0.142870696179425,0.0856102545399422,"MAPK14/RPS6KA3/MAPK3",3
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","5/130","49/2914",0.064912749534519,0.144079987987091,0.0863348802486135,"RPS6KA3/SRC/MAPK3/PRKAA1/RAC1",5
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","2/130","10/2914",0.0702898090359577,0.151909225449422,0.0910262762446267,"E2F1/TFDP1",2
"R-HSA-209560","R-HSA-209560","NF-kB is activated and signals survival","2/130","10/2914",0.0702898090359577,0.151909225449422,0.0910262762446267,"NGF/NFKB1",2
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","2/130","10/2914",0.0702898090359577,0.151909225449422,0.0910262762446267,"EP300/GSK3B",2
"R-HSA-75892","R-HSA-75892","Platelet Adhesion to exposed collagen","2/130","10/2914",0.0702898090359577,0.151909225449422,0.0910262762446267,"FYN/LYN",2
"R-HSA-8875360","R-HSA-8875360","InlB-mediated entry of Listeria monocytogenes into host cell","2/130","10/2914",0.0702898090359577,0.151909225449422,0.0910262762446267,"MET/CBL",2
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","2/130","10/2914",0.0702898090359577,0.151909225449422,0.0910262762446267,"STAT1/STAT3",2
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","2/130","10/2914",0.0702898090359577,0.151909225449422,0.0910262762446267,"STAT1/STAT3",2
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","2/130","10/2914",0.0702898090359577,0.151909225449422,0.0910262762446267,"CREBBP/EP300",2
"R-HSA-69275","R-HSA-69275","G2/M Transition","6/130","66/2914",0.0715749853168225,0.152966443252635,0.0916597769390138,"CDK1/CSNK1D/EP300/TP53/MYBL2/FOXM1",6
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","3/130","22/2914",0.0719431217124265,0.152966443252635,0.0916597769390138,"SMAD2/SMAD3/TGFBR1",3
"R-HSA-525793","R-HSA-525793","Myogenesis","3/130","22/2914",0.0719431217124265,0.152966443252635,0.0916597769390138,"MAPK14/CTNNB1/CDC42",3
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","3/130","22/2914",0.0719431217124265,0.152966443252635,0.0916597769390138,"CCNE1/MDM2/TP53",3
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","3/130","22/2914",0.0719431217124265,0.152966443252635,0.0916597769390138,"CCNE1/MDM2/TP53",3
"R-HSA-8875878","R-HSA-8875878","MET promotes cell motility","4/130","36/2914",0.0739843328950282,0.156799053909786,0.093956334474501,"MET/PTK2/SRC/RAC1",4
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","3/130","23/2914",0.0801386147975734,0.168753429237198,0.1011195746771,"CDK1/MAP2K1/MAPK3",3
"R-HSA-948021","R-HSA-948021","Transport to the Golgi and subsequent modification","3/130","23/2914",0.0801386147975734,0.168753429237198,0.1011195746771,"AREG/CSNK1D/TGFA",3
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","2/130","11/2914",0.0834649851437735,0.172985789398925,0.103655668084912,"STAT3/SOCS3",2
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","2/130","11/2914",0.0834649851437735,0.172985789398925,0.103655668084912,"CREBBP/EP300",2
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","2/130","11/2914",0.0834649851437735,0.172985789398925,0.103655668084912,"CDK1/YWHAQ",2
"R-HSA-8875555","R-HSA-8875555","MET activates RAP1 and RAC1","2/130","11/2914",0.0834649851437735,0.172985789398925,0.103655668084912,"MET/RAC1",2
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","2/130","11/2914",0.0834649851437735,0.172985789398925,0.103655668084912,"STAT1/STAT3",2
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","5/130","53/2914",0.0850001710242006,0.17506304815956,0.104900392552552,"PRKCD/SRC/MAP3K7/NFKB1/NFATC1",5
"R-HSA-8856825","R-HSA-8856825","Cargo recognition for clathrin-mediated endocytosis","5/130","53/2914",0.0850001710242006,0.17506304815956,0.104900392552552,"EGFR/AREG/CBL/EREG/TGFA",5
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","3/130","24/2914",0.0887203197012806,0.179905092727597,0.10780181796062,"MAPK14/RPS6KA3/MAPK3",3
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","3/130","24/2914",0.0887203197012806,0.179905092727597,0.10780181796062,"GSK3A/GSK3B/MDM2",3
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","3/130","24/2914",0.0887203197012806,0.179905092727597,0.10780181796062,"CCNE1/MDM2/TP53",3
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","3/130","24/2914",0.0887203197012806,0.179905092727597,0.10780181796062,"EGFR/ERBB2/EREG",3
"R-HSA-9006335","R-HSA-9006335","Signaling by Erythropoietin","3/130","24/2914",0.0887203197012806,0.179905092727597,0.10780181796062,"PIK3CA/LYN/PIK3R1",3
"R-HSA-69242","R-HSA-69242","S Phase","6/130","71/2914",0.0944617356661602,0.190958031792822,0.114424904094393,"E2F1/CCNE1/GSK3B/E2F4/MAX/TFDP1",6
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","7/130","88/2914",0.0951002708352263,0.191659134781422,0.114845015474248,"RPS6KA3/MDM2/SRC/MAPK3/PRKAA1/PRKCA/RAC1",7
"R-HSA-202427","R-HSA-202427","Phosphorylation of CD3 and TCR zeta chains","2/130","12/2914",0.0973186623980303,0.194341523390595,0.116452342783117,"LCK/PTPRC",2
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","2/130","12/2914",0.0973186623980303,0.194341523390595,0.116452342783117,"CTNNB1/TCF7L2",2
"R-HSA-399954","R-HSA-399954","Sema3A PAK dependent Axon repulsion","2/130","12/2914",0.0973186623980303,0.194341523390595,0.116452342783117,"FYN/RAC1",2
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","5/130","56/2914",0.101983102746482,0.203039086377087,0.121664052399312,"CDK5/MAPK14/MDM2/TP53/PRKAA1",5
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","3/130","26/2914",0.106971858308735,0.212327827519152,0.12723000479398,"CTNNB1/PRKCD/PTK2",3
"R-HSA-171007","R-HSA-171007","p38MAPK events","2/130","13/2914",0.111765163508227,0.214706761476331,0.128655497544096,"MAPK14/SRC",2
"R-HSA-193639","R-HSA-193639","p75NTR signals via NF-kB","2/130","13/2914",0.111765163508227,0.214706761476331,0.128655497544096,"NGF/NFKB1",2
"R-HSA-354194","R-HSA-354194","GRB2:SOS provides linkage to MAPK signaling for Integrins ","2/130","13/2914",0.111765163508227,0.214706761476331,0.128655497544096,"PTK2/SRC",2
"R-HSA-372708","R-HSA-372708","p130Cas linkage to MAPK signaling for integrins","2/130","13/2914",0.111765163508227,0.214706761476331,0.128655497544096,"PTK2/SRC",2
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","2/130","13/2914",0.111765163508227,0.214706761476331,0.128655497544096,"AXIN1/GSK3B",2
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","2/130","13/2914",0.111765163508227,0.214706761476331,0.128655497544096,"AXIN1/GSK3B",2
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","2/130","13/2914",0.111765163508227,0.214706761476331,0.128655497544096,"AXIN1/GSK3B",2
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","2/130","13/2914",0.111765163508227,0.214706761476331,0.128655497544096,"AXIN1/GSK3B",2
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","2/130","13/2914",0.111765163508227,0.214706761476331,0.128655497544096,"AXIN1/GSK3B",2
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","2/130","13/2914",0.111765163508227,0.214706761476331,0.128655497544096,"AXIN1/GSK3B",2
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","2/130","13/2914",0.111765163508227,0.214706761476331,0.128655497544096,"CREBBP/EP300",2
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","8/130","110/2914",0.114916544628386,0.220117113180319,0.131897461074164,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","3/130","27/2914",0.116604930359512,0.220142066799423,0.131912413655346,"EREG/ESR1/SRC",3
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","3/130","27/2914",0.116604930359512,0.220142066799423,0.131912413655346,"CREBBP/EP300/JUN",3
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","3/130","27/2914",0.116604930359512,0.220142066799423,0.131912413655346,"CREBBP/EP300/JUN",3
"R-HSA-8874081","R-HSA-8874081","MET activates PTK2 signaling","3/130","27/2914",0.116604930359512,0.220142066799423,0.131912413655346,"MET/PTK2/SRC",3
"R-HSA-983695","R-HSA-983695","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers","3/130","27/2914",0.116604930359512,0.220142066799423,0.131912413655346,"FYN/LYN/PIK3R1",3
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","4/130","43/2914",0.122661868297842,0.230913603070723,0.138366879033006,"PTK2/MAPK3/CDC42/RAC1",4
"R-HSA-2173791","R-HSA-2173791","TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)","2/130","14/2914",0.126725002601686,0.234530497772697,0.140534176347014,"PARD6A/TGFBR1",2
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","2/130","14/2914",0.126725002601686,0.234530497772697,0.140534176347014,"CREBBP/SREBF1",2
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","2/130","14/2914",0.126725002601686,0.234530497772697,0.140534176347014,"CTNNB1/TCF7L2",2
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","2/130","14/2914",0.126725002601686,0.234530497772697,0.140534176347014,"EP300/TP53",2
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","2/130","14/2914",0.126725002601686,0.234530497772697,0.140534176347014,"STAT1/SOCS3",2
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","2/130","14/2914",0.126725002601686,0.234530497772697,0.140534176347014,"CREBBP/EP300",2
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","7/130","95/2914",0.128728207293573,0.237568629752464,0.142354670395613,"CDK5/MAPK14/CDK1/EP300/MDM2/TP53/PRKAA1",7
"R-HSA-4086400","R-HSA-4086400","PCP/CE pathway","4/130","44/2914",0.130524454215813,0.240208869523219,0.143936741491122,"DVL1/PARD6A/PRKCA/RAC1",4
"R-HSA-168249","R-HSA-168249","Innate Immune System","24/130","428/2914",0.133078210667542,0.24422453745412,0.146342989678508,"CREBBP/MAPK14/PRKDC/RPS6KA3/TNIP2/CTNNB1/PIK3CA/PRKCD/EP300/MAP2K1/FYN/PTK2/SRC/LCK/LYN/MAPK3/PTPRC/CDC42/MAP3K7/PIK3R1/RAC1/NFKB1/JUN/NFATC1",24
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","3/130","29/2914",0.136790772409907,0.24964315964808,0.149589909009664,"CDK1/MDM2/TP53",3
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","3/130","29/2914",0.136790772409907,0.24964315964808,0.149589909009664,"CDK1/MDM2/TP53",3
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","5/130","62/2914",0.140551144687733,0.253738595612529,0.152043955393873,"CDK5/TP53/CDC42/RAC1/GATA2",5
"R-HSA-1660499","R-HSA-1660499","Synthesis of PIPs at the plasma membrane","2/130","15/2914",0.142124510175663,0.253738595612529,0.152043955393873,"PIK3CA/PIK3R1",2
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","2/130","15/2914",0.142124510175663,0.253738595612529,0.152043955393873,"EP300/GSK3B",2
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","2/130","15/2914",0.142124510175663,0.253738595612529,0.152043955393873,"CREBBP/TP53",2
"R-HSA-69541","R-HSA-69541","Stabilization of p53","2/130","15/2914",0.142124510175663,0.253738595612529,0.152043955393873,"MDM2/TP53",2
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","2/130","15/2914",0.142124510175663,0.253738595612529,0.152043955393873,"CDK5/JUN",2
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","2/130","15/2914",0.142124510175663,0.253738595612529,0.152043955393873,"CDK5/JUN",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/130","15/2914",0.142124510175663,0.253738595612529,0.152043955393873,"STAT3/SMAD3",2
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","5/130","64/2914",0.154659741848651,0.27536978426711,0.165005686639268,"CREBBP/EP300/FBXW7/NOTCH1/HIF1A",5
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","6/130","82/2914",0.156796129945184,0.276945616168027,0.165949948645105,"STAT3/TNIP2/MAP2K1/MAP3K7/SMAD3/NFKB1",6
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","2/130","16/2914",0.157895478793225,0.276945616168027,0.165949948645105,"MDM2/TP53",2
"R-HSA-5627123","R-HSA-5627123","RHO GTPases activate PAKs","2/130","16/2914",0.157895478793225,0.276945616168027,0.165949948645105,"CDC42/RAC1",2
"R-HSA-6807004","R-HSA-6807004","Negative regulation of MET activity","2/130","16/2914",0.157895478793225,0.276945616168027,0.165949948645105,"MET/CBL",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/130","16/2914",0.157895478793225,0.276945616168027,0.165949948645105,"CDK1/TP53",2
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","3/130","31/2914",0.158073981831066,0.276945616168027,0.165949948645105,"MAPK14/PRKCD/PRKCA",3
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","3/130","32/2914",0.169078641034182,0.293543880046085,0.175895876211224,"STAT1/STAT3/CDC42",3
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","3/130","32/2914",0.169078641034182,0.293543880046085,0.175895876211224,"MAP2K1/SRC/MAPK3",3
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","3/130","32/2914",0.169078641034182,0.293543880046085,0.175895876211224,"TP53/MAPK3/JUN",3
"R-HSA-8856828","R-HSA-8856828","Clathrin-mediated endocytosis","5/130","66/2914",0.169335054090511,0.293543880046085,0.175895876211224,"EGFR/AREG/CBL/EREG/TGFA",5
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","4/130","49/2914",0.172742427869241,0.298437238341655,0.178828049571063,"CREBBP/EP300/GSK3B/MAPK3",4
"R-HSA-399719","R-HSA-399719","Trafficking of AMPA receptors","2/130","17/2914",0.173974828439656,0.298437238341655,0.178828049571063,"MDM2/PRKCA",2
"R-HSA-399721","R-HSA-399721","Glutamate binding, activation of AMPA receptors and synaptic plasticity","2/130","17/2914",0.173974828439656,0.298437238341655,0.178828049571063,"MDM2/PRKCA",2
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","2/130","17/2914",0.173974828439656,0.298437238341655,0.178828049571063,"MAPK14/SRC",2
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","3/130","33/2914",0.180299676835093,0.308481478335042,0.184846708158785,"CDK1/MAPK3/PRKCA",3
"R-HSA-112316","R-HSA-112316","Neuronal System","7/130","105/2914",0.185677369215636,0.31685722486928,0.189865580551327,"RPS6KA3/MDM2/SRC/MAPK3/PRKAA1/PRKCA/RAC1",7
"R-HSA-1483255","R-HSA-1483255","PI Metabolism","2/130","18/2914",0.190304290510471,0.318077745382032,0.190596934667756,"PIK3CA/PIK3R1",2
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","2/130","18/2914",0.190304290510471,0.318077745382032,0.190596934667756,"CDK1/FOXM1",2
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","9/130","144/2914",0.190344148687728,0.318077745382032,0.190596934667756,"EGFR/AREG/CBL/CSNK1D/YWHAQ/EREG/SRC/TGFA/RAC1",9
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","4/130","51/2914",0.190823310803268,0.318077745382032,0.190596934667756,"CREBBP/EP300/FBXW7/NOTCH1",4
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","4/130","51/2914",0.190823310803268,0.318077745382032,0.190596934667756,"CREBBP/EP300/FBXW7/NOTCH1",4
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","4/130","51/2914",0.190823310803268,0.318077745382032,0.190596934667756,"CREBBP/EP300/FBXW7/NOTCH1",4
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","4/130","51/2914",0.190823310803268,0.318077745382032,0.190596934667756,"CREBBP/EP300/FBXW7/NOTCH1",4
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","4/130","51/2914",0.190823310803268,0.318077745382032,0.190596934667756,"CREBBP/EP300/FBXW7/NOTCH1",4
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","3/130","34/2914",0.191718093106978,0.318077745382032,0.190596934667756,"CREBBP/EP300/CLOCK",3
"R-HSA-446203","R-HSA-446203","Asparagine N-linked glycosylation","3/130","34/2914",0.191718093106978,0.318077745382032,0.190596934667756,"AREG/CSNK1D/TGFA",3
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","3/130","34/2914",0.191718093106978,0.318077745382032,0.190596934667756,"MAP2K1/SRC/MAPK3",3
"R-HSA-5663205","R-HSA-5663205","Infectious disease","8/130","126/2914",0.197542365920945,0.326915200025342,0.195892469453621,"MET/CBL/CTNNB1/MAP2K1/FYN/SRC/LCK/RAC1",8
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","3/130","35/2914",0.203315169928604,0.334907525732085,0.200681590360971,"TP53/YWHAQ/PRKAA1",3
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","8/130","127/2914",0.203391328412636,0.334907525732085,0.200681590360971,"MAPK14/RPS6KA3/TNIP2/MAP2K1/MAPK3/MAP3K7/NFKB1/JUN",8
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","2/130","19/2914",0.206830109453766,0.337189533278224,0.202049003358256,"CREBBP/CLOCK",2
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","2/130","19/2914",0.206830109453766,0.337189533278224,0.202049003358256,"CDK1/PRKCA",2
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","2/130","19/2914",0.206830109453766,0.337189533278224,0.202049003358256,"CREBBP/EP300",2
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","2/130","19/2914",0.206830109453766,0.337189533278224,0.202049003358256,"CTNNB1/PARD6A",2
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","21/130","393/2914",0.21441263669944,0.348685896810723,0.20893779605417,"CREBBP/PRKDC/TNIP2/AREG/CDK1/AXIN1/CSNK1D/EP300/FBXW7/MDM2/TP53/FGF23/ESR1/SOCS3/TGFA/MAP3K7/SMAD2/SMAD3/SMAD4/TGFBR1/HIF1A",21
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","2/130","20/2914",0.223502761138776,0.361678113468413,0.216722926279238,"CREBBP/SREBF1",2
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","2/130","20/2914",0.223502761138776,0.361678113468413,0.216722926279238,"RPS6KA3/SRC",2
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","3/130","38/2914",0.238996416438517,0.385800112039572,0.231177188020187,"LYN/MAP3K7/NFKB1",3
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","2/130","21/2914",0.24027668706928,0.386916135795385,0.231845926119481,"MAPK14/MAP3K7",2
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","4/130","57/2914",0.248215669580702,0.398722970451152,0.238920757748507,"TNIP2/MAP2K1/MAP3K7/NFKB1",4
"R-HSA-1168372","R-HSA-1168372","Downstream signaling events of B Cell Receptor (BCR)","3/130","39/2914",0.25112824468741,0.402417699413728,0.241134694513713,"MAP3K7/NFKB1/NFATC1",3
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","2/130","22/2914",0.257110043604966,0.409010408349788,0.245085144152561,"STAT3/PIK3R1",2
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","2/130","22/2914",0.257110043604966,0.409010408349788,0.245085144152561,"RPS6KA3/MAPK3",2
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","2/130","22/2914",0.257110043604966,0.409010408349788,0.245085144152561,"EP300/SREBF1",2
"R-HSA-392518","R-HSA-392518","Signal amplification","2/130","23/2914",0.273964465396146,0.434769695085188,0.260520493410014,"MAPK14/SRC",2
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","3/130","41/2914",0.275648454111943,0.43638803458204,0.261490226602072,"MET/BDNF/SOX2",3
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","7/130","119/2914",0.279296200165783,0.441100008434903,0.264313711695352,"CREBBP/PIK3CA/EP300/PIK3R1/CLOCK/ARNT/SREBF1",7
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","9/130","160/2914",0.282857884475861,0.445653789210169,0.267042405134348,"EGFR/AREG/CBL/CSNK1D/YWHAQ/EREG/SRC/TGFA/RAC1",9
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","3/130","42/2914",0.288005096061943,0.447444452871934,0.268115397539219,"CTNNB1/KLF4/TCF7L2",3
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","3/130","42/2914",0.288005096061943,0.447444452871934,0.268115397539219,"MAP2K1/SRC/MAPK3",3
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","3/130","42/2914",0.288005096061943,0.447444452871934,0.268115397539219,"MAP2K1/SRC/MAPK3",3
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","3/130","42/2914",0.288005096061943,0.447444452871934,0.268115397539219,"MAP2K1/SRC/MAPK3",3
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","3/130","42/2914",0.288005096061943,0.447444452871934,0.268115397539219,"MAP2K1/SRC/MAPK3",3
"R-HSA-1169091","R-HSA-1169091","Activation of NF-kappaB in B cells","2/130","24/2914",0.290804842277498,0.447444452871934,0.268115397539219,"MAP3K7/NFKB1",2
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","2/130","24/2914",0.290804842277498,0.447444452871934,0.268115397539219,"CCNE1/TP53",2
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","2/130","24/2914",0.290804842277498,0.447444452871934,0.268115397539219,"YWHAQ/RAC1",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/130","24/2914",0.290804842277498,0.447444452871934,0.268115397539219,"STAT1/STAT3",2
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","2/130","24/2914",0.290804842277498,0.447444452871934,0.268115397539219,"STAT1/SOCS3",2
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","2/130","25/2914",0.307599108904713,0.46458072310436,0.278383706546552,"PRKCD/PRKCA",2
"R-HSA-111997","R-HSA-111997","CaM pathway","2/130","25/2914",0.307599108904713,0.46458072310436,0.278383706546552,"PRKCD/PRKCA",2
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","2/130","25/2914",0.307599108904713,0.46458072310436,0.278383706546552,"PTK2/SRC",2
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","2/130","25/2914",0.307599108904713,0.46458072310436,0.278383706546552,"CDK1/CSNK1D",2
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","2/130","25/2914",0.307599108904713,0.46458072310436,0.278383706546552,"CDK1/CSNK1D",2
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/130","25/2914",0.307599108904713,0.46458072310436,0.278383706546552,"SRC/MAPK3",2
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","2/130","25/2914",0.307599108904713,0.46458072310436,0.278383706546552,"CTNNB1/RAC1",2
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","2/130","25/2914",0.307599108904713,0.46458072310436,0.278383706546552,"PTK2/SRC",2
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","12/130","228/2914",0.316333672678782,0.476677116857706,0.285632046310634,"MAPK14/CTNNB1/PRKCD/DVL1/YWHAQ/PTK2/SRC/MAPK3/CDC42/PRKCA/RAC1/SRF",12
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","4/130","64/2914",0.319083172905531,0.479720010523877,0.287455393632828,"SRC/CDC42/PRKCA/RAC1",4
"R-HSA-111996","R-HSA-111996","Ca-dependent events","2/130","26/2914",0.324318046454378,0.480986357834145,0.288214207850629,"PRKCD/PRKCA",2
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","2/130","26/2914",0.324318046454378,0.480986357834145,0.288214207850629,"YWHAQ/RAC1",2
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","2/130","26/2914",0.324318046454378,0.480986357834145,0.288214207850629,"CREBBP/NOTCH1",2
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","2/130","26/2914",0.324318046454378,0.480986357834145,0.288214207850629,"CDK1/CSNK1D",2
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","2/130","26/2914",0.324318046454378,0.480986357834145,0.288214207850629,"CDK1/CSNK1D",2
"R-HSA-912526","R-HSA-912526","Interleukin receptor SHC signaling","2/130","26/2914",0.324318046454378,0.480986357834145,0.288214207850629,"PIK3CA/PIK3R1",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","3/130","46/2914",0.337730543158465,0.498626891809239,0.298784679222391,"MAP2K1/SRC/MAPK3",3
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","3/130","46/2914",0.337730543158465,0.498626891809239,0.298784679222391,"CDK1/TP53/YWHAQ",3
"R-HSA-165159","R-HSA-165159","mTOR signalling","2/130","27/2914",0.340935095741967,0.498873848335128,0.298932659260335,"RPS6KB1/PRKAA1",2
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","2/130","27/2914",0.340935095741967,0.498873848335128,0.298932659260335,"CDK1/CSNK1D",2
"R-HSA-380287","R-HSA-380287","Centrosome maturation","2/130","27/2914",0.340935095741967,0.498873848335128,0.298932659260335,"CDK1/CSNK1D",2
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","2/130","27/2914",0.340935095741967,0.498873848335128,0.298932659260335,"MAP3K7/NFKB1",2
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","3/130","47/2914",0.350168426793939,0.511245903119151,0.306346179230253,"STAT1/PRKCD/SOCS3",3
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","2/130","28/2914",0.357426181145772,0.518386315701484,0.310624821072426,"CDK1/CSNK1D",2
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","2/130","28/2914",0.357426181145772,0.518386315701484,0.310624821072426,"CREBBP/SREBF1",2
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","2/130","28/2914",0.357426181145772,0.518386315701484,0.310624821072426,"CREBBP/EP300",2
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","3/130","48/2914",0.362583654903666,0.519489434413546,0.311285826276802,"MAPK14/MAP3K7/NFKB1",3
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","1/130","10/2914",0.366884471183996,0.519489434413546,0.311285826276802,"MAPK3",1
"R-HSA-114508","R-HSA-114508","Effects of PIP2 hydrolysis","1/130","10/2914",0.366884471183996,0.519489434413546,0.311285826276802,"PRKCD",1
"R-HSA-164938","R-HSA-164938","Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters","1/130","10/2914",0.366884471183996,0.519489434413546,0.311285826276802,"LCK",1
"R-HSA-2025928","R-HSA-2025928","Calcineurin activates NFAT","1/130","10/2914",0.366884471183996,0.519489434413546,0.311285826276802,"NFATC1",1
"R-HSA-211945","R-HSA-211945","Phase I - Functionalization of compounds","1/130","10/2914",0.366884471183996,0.519489434413546,0.311285826276802,"ARNT",1
"R-HSA-381038","R-HSA-381038","XBP1(S) activates chaperone genes","1/130","10/2914",0.366884471183996,0.519489434413546,0.311285826276802,"GSK3A",1
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","1/130","10/2914",0.366884471183996,0.519489434413546,0.311285826276802,"TP53",1
"R-HSA-74749","R-HSA-74749","Signal attenuation","1/130","10/2914",0.366884471183996,0.519489434413546,0.311285826276802,"MAPK3",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/130","10/2914",0.366884471183996,0.519489434413546,0.311285826276802,"SRC",1
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","1/130","10/2914",0.366884471183996,0.519489434413546,0.311285826276802,"MAPK3",1
"R-HSA-2871809","R-HSA-2871809","FCERI mediated Ca+2 mobilization","2/130","29/2914",0.373769544755836,0.524152649259178,0.314080094244865,"LYN/NFATC1",2
"R-HSA-418597","R-HSA-418597","G alpha (z) signalling events","2/130","29/2914",0.373769544755836,0.524152649259178,0.314080094244865,"PRKCD/PRKCA",2
"R-HSA-5673000","R-HSA-5673000","RAF activation","2/130","29/2914",0.373769544755836,0.524152649259178,0.314080094244865,"MAP2K1/SRC",2
"R-HSA-162909","R-HSA-162909","Host Interactions of HIV factors","3/130","49/2914",0.374964604492867,0.524152649259178,0.314080094244865,"FYN/LCK/RAC1",3
"R-HSA-3000171","R-HSA-3000171","Non-integrin membrane-ECM interactions","3/130","49/2914",0.374964604492867,0.524152649259178,0.314080094244865,"PDGFA/PDGFB/PRKCA",3
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","3/130","49/2914",0.374964604492867,0.524152649259178,0.314080094244865,"MAP2K1/SRC/MAPK3",3
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","2/130","30/2914",0.38994559019673,0.533190467763302,0.319495690048025,"PIK3CA/PIK3R1",2
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","2/130","30/2914",0.38994559019673,0.533190467763302,0.319495690048025,"PRKCD/PRKCA",2
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","2/130","30/2914",0.38994559019673,0.533190467763302,0.319495690048025,"CREBBP/TP53",2
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","1/130","11/2914",0.395226419788018,0.533190467763302,0.319495690048025,"ERBB2",1
"R-HSA-1834941","R-HSA-1834941","STING mediated induction of host immune responses","1/130","11/2914",0.395226419788018,0.533190467763302,0.319495690048025,"PRKDC",1
"R-HSA-193692","R-HSA-193692","Regulated proteolysis of p75NTR","1/130","11/2914",0.395226419788018,0.533190467763302,0.319495690048025,"NFKB1",1
"R-HSA-209543","R-HSA-209543","p75NTR recruits signalling complexes","1/130","11/2914",0.395226419788018,0.533190467763302,0.319495690048025,"NGF",1
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","1/130","11/2914",0.395226419788018,0.533190467763302,0.319495690048025,"EP300",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/130","11/2914",0.395226419788018,0.533190467763302,0.319495690048025,"TP53",1
"R-HSA-416572","R-HSA-416572","Sema4D induced cell migration and growth-cone collapse","1/130","11/2914",0.395226419788018,0.533190467763302,0.319495690048025,"ERBB2",1
"R-HSA-5099900","R-HSA-5099900","WNT5A-dependent internalization of FZD4","1/130","11/2914",0.395226419788018,0.533190467763302,0.319495690048025,"PRKCA",1
"R-HSA-5210891","R-HSA-5210891","Uptake and function of anthrax toxins","1/130","11/2914",0.395226419788018,0.533190467763302,0.319495690048025,"MAP2K1",1
"R-HSA-5607763","R-HSA-5607763","CLEC7A (Dectin-1) induces NFAT activation","1/130","11/2914",0.395226419788018,0.533190467763302,0.319495690048025,"NFATC1",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/130","11/2914",0.395226419788018,0.533190467763302,0.319495690048025,"TP53",1
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","1/130","11/2914",0.395226419788018,0.533190467763302,0.319495690048025,"GSK3B",1
"R-HSA-8963889","R-HSA-8963889","Assembly of active LPL and LIPC lipase complexes","1/130","11/2914",0.395226419788018,0.533190467763302,0.319495690048025,"FGF21",1
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","1/130","11/2914",0.395226419788018,0.533190467763302,0.319495690048025,"YWHAQ",1
"R-HSA-8951664","R-HSA-8951664","Neddylation","3/130","51/2914",0.399580031974739,0.53795918239222,0.322353175061588,"FBXW7/SOCS3/HIF1A",3
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","2/130","32/2914",0.421727275239064,0.548333944019624,0.328569887147864,"GSK3B/MAPK3",2
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"MAPK3",1
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"MAPK3",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"RUNX2",1
"R-HSA-2691230","R-HSA-2691230","Signaling by NOTCH1 HD Domain Mutants in Cancer","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"NOTCH1",1
"R-HSA-2691232","R-HSA-2691232","Constitutive Signaling by NOTCH1 HD Domain Mutants","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"NOTCH1",1
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"CDK1",1
"R-HSA-381070","R-HSA-381070","IRE1alpha activates chaperones","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"GSK3A",1
"R-HSA-389948","R-HSA-389948","PD-1 signaling","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"LCK",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"CTNNB1",1
"R-HSA-425407","R-HSA-425407","SLC-mediated transmembrane transport","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"FGF21",1
"R-HSA-6791226","R-HSA-6791226","Major pathway of rRNA processing in the nucleolus and cytosol","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"CSNK1D",1
"R-HSA-72312","R-HSA-72312","rRNA processing","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"CSNK1D",1
"R-HSA-844456","R-HSA-844456","The NLRP3 inflammasome","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"NFKB1",1
"R-HSA-8868773","R-HSA-8868773","rRNA processing in the nucleus and cytosol","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"CSNK1D",1
"R-HSA-9020558","R-HSA-9020558","Interleukin-2 signaling","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"LCK",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"MET",1
"R-HSA-975163","R-HSA-975163","IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation","1/130","12/2914",0.422308943187108,0.548333944019624,0.328569887147864,"MAP3K7",1
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","2/130","33/2914",0.437303249329642,0.565567391357431,0.338896426127821,"MAPK14/MAP3K7",2
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","2/130","33/2914",0.437303249329642,0.565567391357431,0.338896426127821,"PTK2/SRC",2
"R-HSA-205043","R-HSA-205043","NRIF signals cell death from the nucleus","1/130","13/2914",0.448187591493681,0.570811085003778,0.34203852566116,"NGF",1
"R-HSA-3906995","R-HSA-3906995","Diseases associated with O-glycosylation of proteins","1/130","13/2914",0.448187591493681,0.570811085003778,0.34203852566116,"NOTCH1",1
"R-HSA-428540","R-HSA-428540","Activation of RAC1","1/130","13/2914",0.448187591493681,0.570811085003778,0.34203852566116,"RAC1",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/130","13/2914",0.448187591493681,0.570811085003778,0.34203852566116,"EP300",1
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","1/130","13/2914",0.448187591493681,0.570811085003778,0.34203852566116,"POU2F1",1
"R-HSA-8964616","R-HSA-8964616","G beta:gamma signalling through CDC42","1/130","13/2914",0.448187591493681,0.570811085003778,0.34203852566116,"CDC42",1
"R-HSA-937072","R-HSA-937072","TRAF6-mediated induction of TAK1 complex within TLR4 complex","1/130","13/2914",0.448187591493681,0.570811085003778,0.34203852566116,"MAP3K7",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","14/130","296/2914",0.450901922736956,0.570811085003778,0.34203852566116,"PIK3CA/FBXW7/FYN/SRC/LCK/LYN/PTPRC/SOCS3/CDC42/MAP3K7/PIK3R1/RAC1/NFKB1/NFATC1",14
"R-HSA-112040","R-HSA-112040","G-protein mediated events","2/130","34/2914",0.452652321593559,0.570811085003778,0.34203852566116,"PRKCD/PRKCA",2
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","2/130","34/2914",0.452652321593559,0.570811085003778,0.34203852566116,"PRKCD/PRKCA",2
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","2/130","34/2914",0.452652321593559,0.570811085003778,0.34203852566116,"STAT1/MAPK3",2
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","2/130","34/2914",0.452652321593559,0.570811085003778,0.34203852566116,"MAP2K1/MAPK3",2
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","2/130","34/2914",0.452652321593559,0.570811085003778,0.34203852566116,"TP53/JUN",2
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","2/130","35/2914",0.467763664118708,0.584032842661881,0.349961200281252,"STAT1/MAPK3",2
"R-HSA-446728","R-HSA-446728","Cell junction organization","2/130","35/2914",0.467763664118708,0.584032842661881,0.349961200281252,"CTNNB1/PARD6A",2
"R-HSA-1250347","R-HSA-1250347","SHC1 events in ERBB4 signaling","1/130","14/2914",0.472915482946912,0.584032842661881,0.349961200281252,"EREG",1
"R-HSA-211859","R-HSA-211859","Biological oxidations","1/130","14/2914",0.472915482946912,0.584032842661881,0.349961200281252,"ARNT",1
"R-HSA-4641257","R-HSA-4641257","Degradation of AXIN","1/130","14/2914",0.472915482946912,0.584032842661881,0.349961200281252,"AXIN1",1
"R-HSA-4641258","R-HSA-4641258","Degradation of DVL","1/130","14/2914",0.472915482946912,0.584032842661881,0.349961200281252,"DVL1",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/130","14/2914",0.472915482946912,0.584032842661881,0.349961200281252,"E2F1",1
"R-HSA-8849471","R-HSA-8849471","PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases","1/130","14/2914",0.472915482946912,0.584032842661881,0.349961200281252,"RAC1",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/130","14/2914",0.472915482946912,0.584032842661881,0.349961200281252,"STAT3",1
"R-HSA-9027284","R-HSA-9027284","Erythropoietin activates RAS","1/130","14/2914",0.472915482946912,0.584032842661881,0.349961200281252,"LYN",1
"R-HSA-9620244","R-HSA-9620244","Long-term potentiation","1/130","14/2914",0.472915482946912,0.584032842661881,0.349961200281252,"SRC",1
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","4/130","80/2914",0.482540230009525,0.594800996465775,0.356413638833934,"CREBBP/MAPK14/CDK1/CSNK1D",4
"R-HSA-111885","R-HSA-111885","Opioid Signalling","3/130","59/2914",0.49473134579654,0.602739009247571,0.361170214625637,"CDK5/PRKCD/PRKCA",3
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","3/130","59/2914",0.49473134579654,0.602739009247571,0.361170214625637,"TP53/MAPK3/JUN",3
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","1/130","15/2914",0.49654340957343,0.602739009247571,0.361170214625637,"YWHAQ",1
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/130","15/2914",0.49654340957343,0.602739009247571,0.361170214625637,"CDK1",1
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","1/130","15/2914",0.49654340957343,0.602739009247571,0.361170214625637,"MAPK14",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/130","15/2914",0.49654340957343,0.602739009247571,0.361170214625637,"FBXW7",1
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","2/130","37/2914",0.497236747354921,0.602739009247571,0.361170214625637,"EP300/GSK3B",2
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","2/130","37/2914",0.497236747354921,0.602739009247571,0.361170214625637,"CDK1/CSNK1D",2
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","2/130","37/2914",0.497236747354921,0.602739009247571,0.361170214625637,"CREBBP/EP300",2
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","2/130","38/2914",0.511583432405833,0.618987688933024,0.37090666612345,"CREBBP/MAPK14",2
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","1/130","16/2914",0.51911993829211,0.620112362650757,0.371580587409089,"MAPK3",1
"R-HSA-166208","R-HSA-166208","mTORC1-mediated signalling","1/130","16/2914",0.51911993829211,0.620112362650757,0.371580587409089,"RPS6KB1",1
"R-HSA-1810476","R-HSA-1810476","RIP-mediated NFkB activation via ZBP1","1/130","16/2914",0.51911993829211,0.620112362650757,0.371580587409089,"NFKB1",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/130","16/2914",0.51911993829211,0.620112362650757,0.371580587409089,"SRC",1
"R-HSA-622312","R-HSA-622312","Inflammasomes","1/130","16/2914",0.51911993829211,0.620112362650757,0.371580587409089,"NFKB1",1
"R-HSA-8950505","R-HSA-8950505","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","1/130","16/2914",0.51911993829211,0.620112362650757,0.371580587409089,"CDC42",1
"R-HSA-8963899","R-HSA-8963899","Plasma lipoprotein remodeling","1/130","16/2914",0.51911993829211,0.620112362650757,0.371580587409089,"FGF21",1
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","5/130","107/2914",0.524694343037567,0.62563372663463,0.374889071154933,"CREBBP/EP300/MDM2/TP53/ESR1",5
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","3/130","62/2914",0.528515745745676,0.629048632164691,0.376935333540967,"CDK1/TP53/YWHAQ",3
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/130","17/2914",0.540691507657888,0.64105494605723,0.384129696107352,"CDK1",1
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","1/130","17/2914",0.540691507657888,0.64105494605723,0.384129696107352,"MDM2",1
"R-HSA-2990846","R-HSA-2990846","SUMOylation","5/130","109/2914",0.541530433883961,0.64105494605723,0.384129696107352,"CREBBP/EP300/MDM2/TP53/ESR1",5
"R-HSA-1234176","R-HSA-1234176","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","1/130","18/2914",0.561302520431266,0.658528135577396,0.394599892182882,"HIF1A",1
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/130","18/2914",0.561302520431266,0.658528135577396,0.394599892182882,"LCK",1
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","1/130","18/2914",0.561302520431266,0.658528135577396,0.394599892182882,"PRKAA1",1
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","1/130","18/2914",0.561302520431266,0.658528135577396,0.394599892182882,"GSK3B",1
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","1/130","18/2914",0.561302520431266,0.658528135577396,0.394599892182882,"EP300",1
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","2/130","42/2914",0.566246746533719,0.661964612940665,0.396659080733491,"CDK1/CSNK1D",2
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","2/130","42/2914",0.566246746533719,0.661964612940665,0.396659080733491,"STAT1/SOCS3",2
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","3/130","66/2914",0.571571673200823,0.667002822900428,0.399678051373484,"CREBBP/EP300/NFKB1",3
"R-HSA-1606322","R-HSA-1606322","ZBP1(DAI) mediated induction of type I IFNs","1/130","19/2914",0.580995432152238,0.672031688246514,0.402691422581425,"NFKB1",1
"R-HSA-2514856","R-HSA-2514856","The phototransduction cascade","1/130","19/2914",0.580995432152238,0.672031688246514,0.402691422581425,"PRKCA",1
"R-HSA-2514859","R-HSA-2514859","Inactivation, recovery and regulation of the phototransduction cascade","1/130","19/2914",0.580995432152238,0.672031688246514,0.402691422581425,"PRKCA",1
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","1/130","19/2914",0.580995432152238,0.672031688246514,0.402691422581425,"GSK3B",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/130","19/2914",0.580995432152238,0.672031688246514,0.402691422581425,"EP300",1
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","5/130","114/2914",0.582382005826361,0.672451630629032,0.402943058327738,"CDK1/CCNE1/MDM2/TP53/YWHAQ",5
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","1/130","20/2914",0.599810835889788,0.681791901694794,0.408539888222147,"MAP3K7",1
"R-HSA-4608870","R-HSA-4608870","Asymmetric localization of PCP proteins","1/130","20/2914",0.599810835889788,0.681791901694794,0.408539888222147,"PARD6A",1
"R-HSA-5260271","R-HSA-5260271","Diseases of Immune System","1/130","20/2914",0.599810835889788,0.681791901694794,0.408539888222147,"NFKB1",1
"R-HSA-5339562","R-HSA-5339562","Uptake and actions of bacterial toxins","1/130","20/2914",0.599810835889788,0.681791901694794,0.408539888222147,"MAP2K1",1
"R-HSA-5602358","R-HSA-5602358","Diseases associated with the TLR signaling cascade","1/130","20/2914",0.599810835889788,0.681791901694794,0.408539888222147,"NFKB1",1
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","1/130","20/2914",0.599810835889788,0.681791901694794,0.408539888222147,"MAPK3",1
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","1/130","20/2914",0.599810835889788,0.681791901694794,0.408539888222147,"MAPK3",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/130","20/2914",0.599810835889788,0.681791901694794,0.408539888222147,"EP300",1
"R-HSA-9013507","R-HSA-9013507","NOTCH3 Activation and Transmission of Signal to the Nucleus","1/130","20/2914",0.599810835889788,0.681791901694794,0.408539888222147,"EGFR",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","7/130","165/2914",0.612487840043148,0.694999155282121,0.416453871786451,"EGFR/RPS6KA3/PIK3CA/PRKCD/MAPK3/PIK3R1/PRKCA",7
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","1/130","21/2914",0.617787543330814,0.697399340151795,0.417892098400659,"NOTCH1",1
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","1/130","21/2914",0.617787543330814,0.697399340151795,0.417892098400659,"CDC42",1
"R-HSA-933542","R-HSA-933542","TRAF6 mediated NF-kB activation","1/130","21/2914",0.617787543330814,0.697399340151795,0.417892098400659,"NFKB1",1
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/130","22/2914",0.634962662365378,0.711894998590535,0.426578113390787,"CDK5",1
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/130","22/2914",0.634962662365378,0.711894998590535,0.426578113390787,"CCNE1",1
"R-HSA-5357956","R-HSA-5357956","TNFR1-induced NFkappaB signaling pathway","1/130","22/2914",0.634962662365378,0.711894998590535,0.426578113390787,"MAP3K7",1
"R-HSA-8866654","R-HSA-8866654","E3 ubiquitin ligases ubiquitinate target proteins","1/130","22/2914",0.634962662365378,0.711894998590535,0.426578113390787,"PRKDC",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","4/130","97/2914",0.637116115516988,0.71309248363656,0.427295664311581,"STAT1/PRKCD/MAPK3/SOCS3",4
"R-HSA-193648","R-HSA-193648","NRAGE signals death through JNK","2/130","48/2914",0.639800854299382,0.71487952597737,0.428366486766861,"NGF/RAC1",2
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/130","23/2914",0.651371671318525,0.722890520365322,0.433166794226757,"SMAD4",1
"R-HSA-3000170","R-HSA-3000170","Syndecan interactions","1/130","23/2914",0.651371671318525,0.722890520365322,0.433166794226757,"PRKCA",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/130","23/2914",0.651371671318525,0.722890520365322,0.433166794226757,"E2F1",1
"R-HSA-9020591","R-HSA-9020591","Interleukin-12 signaling","1/130","23/2914",0.651371671318525,0.722890520365322,0.433166794226757,"CDC42",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","5/130","125/2914",0.665009540208974,0.73678122751652,0.441490313372071,"MAPK14/PRKCD/PTPRC/RAC1/NFKB1",5
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","3/130","76/2914",0.668085396377712,0.738942938417772,0.442785642823435,"NGF/RAC1/NFKB1",3
"R-HSA-69306","R-HSA-69306","DNA Replication","2/130","51/2914",0.67277441452822,0.742878639235362,0.445143973522431,"E2F1/CCNE1",2
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","2/130","53/2914",0.693381492425555,0.764348390140252,0.458008968857573,"SRC/PRKAA1",2
"R-HSA-68886","R-HSA-68886","M Phase","4/130","105/2914",0.698765540403823,0.768487629194974,0.460489262707555,"CDK1/CSNK1D/MAPK3/PRKCA",4
"R-HSA-162906","R-HSA-162906","HIV Infection","3/130","80/2914",0.702015291169375,0.768487629194974,0.460489262707555,"FYN/LCK/RAC1",3
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","4/130","106/2914",0.705925753136621,0.768487629194974,0.460489262707555,"NGF/MAP3K7/RAC1/NFKB1",4
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/130","27/2914",0.710003030321689,0.768487629194974,0.460489262707555,"CDK1",1
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/130","27/2914",0.710003030321689,0.768487629194974,0.460489262707555,"NOTCH1",1
"R-HSA-5689603","R-HSA-5689603","UCH proteinases","1/130","27/2914",0.710003030321689,0.768487629194974,0.460489262707555,"TGFBR1",1
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","1/130","27/2914",0.710003030321689,0.768487629194974,0.460489262707555,"PRKDC",1
"R-HSA-69017","R-HSA-69017","CDK-mediated phosphorylation and removal of Cdc6","1/130","27/2914",0.710003030321689,0.768487629194974,0.460489262707555,"CCNE1",1
"R-HSA-75893","R-HSA-75893","TNF signaling","1/130","27/2914",0.710003030321689,0.768487629194974,0.460489262707555,"MAP3K7",1
"R-HSA-8852135","R-HSA-8852135","Protein ubiquitination","1/130","27/2914",0.710003030321689,0.768487629194974,0.460489262707555,"PRKDC",1
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","1/130","27/2914",0.710003030321689,0.768487629194974,0.460489262707555,"GATA2",1
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","2/130","56/2914",0.722290524623085,0.777498135708614,0.465888492758186,"CDK1/CSNK1D",2
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/130","28/2914",0.723061432143019,0.777498135708614,0.465888492758186,"CDK1",1
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","1/130","28/2914",0.723061432143019,0.777498135708614,0.465888492758186,"ESR1",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/130","28/2914",0.723061432143019,0.777498135708614,0.465888492758186,"EP300",1
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","4/130","109/2914",0.726674230934747,0.777565097270568,0.465928617125999,"CREBBP/EP300/CLOCK/NFKB1",4
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","4/130","109/2914",0.726674230934747,0.777565097270568,0.465928617125999,"CREBBP/EP300/CLOCK/NFKB1",4
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","4/130","109/2914",0.726674230934747,0.777565097270568,0.465928617125999,"MAPK14/PRKCD/CSNK1D/PRKCA",4
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/130","29/2914",0.735536142406847,0.783220819386221,0.469317610270683,"CDK1",1
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","1/130","29/2914",0.735536142406847,0.783220819386221,0.469317610270683,"EP300",1
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","1/130","29/2914",0.735536142406847,0.783220819386221,0.469317610270683,"GSK3A",1
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/130","30/2914",0.747453058000299,0.794622425738182,0.476149623049075,"CDK1",1
"R-HSA-174824","R-HSA-174824","Plasma lipoprotein assembly, remodeling, and clearance","1/130","31/2914",0.758836935413601,0.804122365430219,0.481842128768568,"FGF21",1
"R-HSA-3214841","R-HSA-3214841","PKMTs methylate histone lysines","1/130","31/2914",0.758836935413601,0.804122365430219,0.481842128768568,"NFKB1",1
"R-HSA-204998","R-HSA-204998","Cell death signalling via NRAGE, NRIF and NADE","2/130","61/2914",0.76538955156447,0.807160409916303,0.483662570389645,"NGF/RAC1",2
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","2/130","61/2914",0.76538955156447,0.807160409916303,0.483662570389645,"FGF23/IGF2",2
"R-HSA-9612973","R-HSA-9612973","Autophagy","2/130","61/2914",0.76538955156447,0.807160409916303,0.483662570389645,"SRC/PRKAA1",2
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/130","32/2914",0.769711440580521,0.809120666338244,0.484837185308825,"CREBBP",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/130","32/2914",0.769711440580521,0.809120666338244,0.484837185308825,"EP300",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/130","33/2914",0.780099196557111,0.817424516966542,0.489812976600956,"EP300",1
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","1/130","33/2914",0.780099196557111,0.817424516966542,0.489812976600956,"CCNE1",1
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","1/130","34/2914",0.790021829131764,0.823879907523126,0.49368114301634,"CDK1",1
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","1/130","34/2914",0.790021829131764,0.823879907523126,0.49368114301634,"CDK1",1
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","1/130","34/2914",0.790021829131764,0.823879907523126,0.49368114301634,"TP53",1
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","1/130","35/2914",0.799500010455678,0.831125802008513,0.498022991189912,"GSK3B",1
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","1/130","35/2914",0.799500010455678,0.831125802008513,0.498022991189912,"TP53",1
"R-HSA-2187338","R-HSA-2187338","Visual phototransduction","1/130","36/2914",0.808553500778971,0.839209557680543,0.502866898297722,"PRKCA",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/130","39/2914",0.833350576054134,0.863582537015088,0.517471551459814,"EP300",1
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","1/130","40/2914",0.840886028267338,0.868651132974278,0.520508729844397,"CDK1",1
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","1/130","40/2914",0.840886028267338,0.868651132974278,0.520508729844397,"CDK1",1
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","1/130","42/2914",0.85495731143996,0.880418422595695,0.527559865498342,"MAPK14",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/130","42/2914",0.85495731143996,0.880418422595695,0.527559865498342,"STAT3",1
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","1/130","44/2914",0.867792924245493,0.892237795351,0.534642210143834,"CCNE1",1
"R-HSA-422356","R-HSA-422356","Regulation of insulin secretion","1/130","45/2914",0.873781398060157,0.89699121644613,0.537490531043583,"PRKCA",1
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","1/130","46/2914",0.879500609720032,0.901453823067177,0.540164591567931,"ESR1",1
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","2/130","81/2914",0.884852021576665,0.905526134230326,0.542604781225894,"PRKDC/TP53",2
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","1/130","50/2914",0.899917334815124,0.919511180363198,0.550984829697727,"FGF23",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","2/130","88/2914",0.911266132294147,0.929661256082694,0.557066906632905,"FBXW7/SOCS3",2
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","1/130","55/2914",0.920674254160995,0.934904149897641,0.560208526895326,"PRKCA",1
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","1/130","55/2914",0.920674254160995,0.934904149897641,0.560208526895326,"GSK3B",1
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","1/130","55/2914",0.920674254160995,0.934904149897641,0.560208526895326,"EP300",1
"R-HSA-1430728","R-HSA-1430728","Metabolism","8/130","289/2914",0.955087322442183,0.967339860833724,0.579644489228251,"CREBBP/PIK3CA/EP300/PIK3R1/PRKCA/CLOCK/ARNT/SREBF1",8
"R-HSA-194840","R-HSA-194840","Rho GTPase cycle","2/130","106/2914",0.955560988860102,0.967339860833724,0.579644489228251,"CDC42/RAC1",2
"R-HSA-418555","R-HSA-418555","G alpha (s) signalling events","1/130","73/2914",0.965761776284065,0.976162287720971,0.584931019158284,"SRC",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","2/130","115/2914",0.968862863170131,0.977792474812253,0.585907851605836,"FBXW7/SOCS3",2
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","3/130","157/2914",0.975729207782224,0.981706109514427,0.588252959958977,"PDGFA/PDGFB/PRKCA",3
"R-HSA-73894","R-HSA-73894","DNA Repair","3/130","157/2914",0.975729207782224,0.981706109514427,0.588252959958977,"PRKDC/EP300/TP53",3
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","4/130","217/2914",0.990433555300208,0.994976828489659,0.596204972931398,"CDK5/PRKCD/SRC/PRKCA",4
"R-HSA-382551","R-HSA-382551","Transport of small molecules","1/130","121/2914",0.99645395232634,0.997996632254842,0.598014484440136,"FGF21",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","10/130","436/2914",0.996477611505595,0.997996632254842,0.598014484440136,"CDK5/EGFR/RPS6KA3/PIK3CA/PRKCD/SRC/MAPK3/CDC42/PIK3R1/PRKCA",10
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","10/130","486/2914",0.999296199389134,0.999296199389134,0.59879320447254,"CDK5/EGFR/RPS6KA3/PIK3CA/PRKCD/SRC/MAPK3/CDC42/PIK3R1/PRKCA",10
